<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38928096</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>09</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6389</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25126389</ELocationID><Abstract><AbstractText>Long COVID (LC), also referred to as Post COVID-19 Condition, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), and other terms, represents a complex multisystem disease persisting after the acute phase of COVID-19. Characterized by a myriad of symptoms across different organ systems, LC presents significant diagnostic and management challenges. Central to the disorder is the role of low-grade inflammation, a non-classical inflammatory response that contributes to the chronicity and diversity of symptoms observed. This review explores the pathophysiological underpinnings of LC, emphasizing the importance of low-grade inflammation as a core component. By delineating the pathogenetic relationships and clinical manifestations of LC, this article highlights the necessity for an integrated approach that employs both personalized medicine and standardized protocols aimed at mitigating long-term consequences. The insights gained not only enhance our understanding of LC but also inform the development of therapeutic strategies that could be applicable to other chronic conditions with similar pathophysiological features.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gusev</LastName><ForeName>Evgenii</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7145-2376</Identifier><AffiliationInfo><Affiliation>Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Science, 620049 Ekaterinburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarapultsev</LastName><ForeName>Alexey</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3101-9655</Identifier><AffiliationInfo><Affiliation>Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Science, 620049 Ekaterinburg, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>122020900136-4</GrantID><Agency>Institute of Immunology and Physiology</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">chronic inflammation</Keyword><Keyword MajorTopicYN="N">diagnostic strategies</Keyword><Keyword MajorTopicYN="N">inflamm-aging</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">low-grade inflammation</Keyword><Keyword MajorTopicYN="N">pathophysiology</Keyword><Keyword MajorTopicYN="N">personalized medicine</Keyword><Keyword MajorTopicYN="N">post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">systemic inflammation</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38928096</ArticleId><ArticleId IdType="pmc">PMC11204317</ArticleId><ArticleId IdType="doi">10.3390/ijms25126389</ArticleId><ArticleId IdType="pii">ijms25126389</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gusev E. Molecular Mechanisms of Pathogenesis, Prevention, and Therapy of COVID-19: Summarizing the Results of 2022. Int. J. Mol. Sci. 2023;24:16073. doi: 10.3390/ijms242216073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms242216073</ArticleId><ArticleId IdType="pmc">PMC10671362</ArticleId><ArticleId IdType="pubmed">38003262</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Ancochea J. On the new post COVID-19 condition. Arch. Bronconeumol. 2021;57:735&#x2013;736. doi: 10.1016/j.arbr.2021.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbr.2021.10.011</ArticleId><ArticleId IdType="pmc">PMC8531201</ArticleId><ArticleId IdType="pubmed">34703072</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Chronic COVID syndrome: Need for an appropriate medical terminology for Long COVID and COVID long-haulers. J. Med. Virol. 2021;93:2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden A.C., Boland J.M., Johnson T.F., Aubry M.C., Lo Y.C., Butt Y.M., Maleszewski J.J., Larsen B.T., Tazelaar H.D., Khoor A., et al. Late Complications of COVID-19. Arch. Pathol. Lab. Med. 2022;146:791&#x2013;804. doi: 10.5858/arpa.2021-0519-SA.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2021-0519-SA</ArticleId><ArticleId IdType="pubmed">35319744</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Long-Haul COVID. Neurology. 2020;95:559&#x2013;560. doi: 10.1212/WNL.0000000000010640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010640</ArticleId><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z.A., Gomez C.R., Connors T.J., Henrich T.J., Reeves W.B., RECOVER Mechanistic Pathway Task Force Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) eLife. 2023;12:e86002. doi: 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner-Scott J., Levy M., Hawkes C., Yeh A., Giovannoni G. Long COVID or post COVID-19 syndrome. Mult. Scler. Relat. Disord. 2021;55:103268. doi: 10.1016/j.msard.2021.103268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103268</ArticleId><ArticleId IdType="pmc">PMC8447548</ArticleId><ArticleId IdType="pubmed">34601388</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G., Sanchis-Gomar F., Henry B.M. COVID-19 and its long-term sequelae: What do we know in 2023? Pol. Arch. Intern. Med. 2023;133:16402. doi: 10.20452/pamw.16402.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16402</ArticleId><ArticleId IdType="pubmed">36626183</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz L.H., Schork N.J. Personalized medicine: Motivation, challenges, and progress. Fertil. Steril. 2018;109:952&#x2013;963. doi: 10.1016/j.fertnstert.2018.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2018.05.006</ArticleId><ArticleId IdType="pmc">PMC6366451</ArticleId><ArticleId IdType="pubmed">29935653</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappaport N., Twik M., Plaschkes I., Nudel R., Iny Stein T., Levitt J., Gershoni M., Morrey C.P., Safran M., Lancet D. MalaCards: An amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 2017;45:D877&#x2013;D887. doi: 10.1093/nar/gkw1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1012</ArticleId><ArticleId IdType="pmc">PMC5210521</ArticleId><ArticleId IdType="pubmed">27899610</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine R.L. Addressing the Long-term Effects of COVID-19. JAMA. 2022;328:823&#x2013;824. doi: 10.1001/jama.2022.14089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.14089</ArticleId><ArticleId IdType="pubmed">35921084</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjenberg Z., Leng S., Tascini C., Garg M., Misso K., El Guerche Seblain C., Shaikh N. Risk of long COVID main symptoms after SARS-CoV-2 infection: A systematic review and meta-analysis. Sci. Rep. 2023;13:15332. doi: 10.1038/s41598-023-42321-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42321-9</ArticleId><ArticleId IdType="pmc">PMC10504382</ArticleId><ArticleId IdType="pubmed">37714919</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Boufidou F., Medi&#x107; S., Lampropoulou V., Siafakas N., Tsakris A., Anastassopoulou C. SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic. Int. J. Mol. Sci. 2023;24:12962. doi: 10.3390/ijms241612962.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241612962</ArticleId><ArticleId IdType="pmc">PMC10454552</ArticleId><ArticleId IdType="pubmed">37629143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha E.K., Kim J.H., Han M.Y. Long COVID in children and adolescents: Prevalence, clinical manifestations, and management strategies. Clin. Exp. Pediatr. 2023;66:465&#x2013;474. doi: 10.3345/cep.2023.00472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/cep.2023.00472</ArticleId><ArticleId IdType="pmc">PMC10626026</ArticleId><ArticleId IdType="pubmed">37350170</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris E. Millions of US Children Experience Range of Long COVID Effects. JAMA. 2024;331:726. doi: 10.1001/jama.2024.0356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2024.0356</ArticleId><ArticleId IdType="pubmed">38353977</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R., Shunmugam L., Naidoo K., Wilkins D., Garzino-Demo A., Brechot C., Vahlne A., Nikolich J. Biological mechanisms underpinning the development of long COVID. iScience. 2023;26:106935. doi: 10.1016/j.isci.2023.106935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.106935</ArticleId><ArticleId IdType="pmc">PMC10193768</ArticleId><ArticleId IdType="pubmed">37265584</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2022;28:e9&#x2013;e611. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerne K., Filion K.B., Grad R., Ernst P., Gershon A.S., Eisenberg M.J. Epidemiological and clinical perspectives of long COVID syndrome. Am. J. Med. Open. 2023;9:100033. doi: 10.1016/j.ajmo.2023.100033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajmo.2023.100033</ArticleId><ArticleId IdType="pmc">PMC9846887</ArticleId><ArticleId IdType="pubmed">36685609</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D., et al. Age, Sex and Previous Comorbidities as Risk Factors not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Udomsinprasert W., Nontawong N., Saengsiwaritt W., Panthan B., Jiaranai P., Thongchompoo N., Santon S., Runcharoen C., Sensorn I., Jittikoon J., et al. Host genetic polymorphisms involved in long-term symptoms of COVID-19. Emerg Microbes Infect. 2023;12:2239952. doi: 10.1080/22221751.2023.2239952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2239952</ArticleId><ArticleId IdType="pmc">PMC10392286</ArticleId><ArticleId IdType="pubmed">37497655</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B. RECOVER Mechanistic Pathways Task Force. Viral persistence, reactivation, and mechanisms of long COVID. eLife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019; Mahony L., Buwalda T., Blair M., Forde B., Lunjani N., Ambikan A., Neogi U., Barrett P., Geary E., O&#x2019;Connor N., et al. Impact of Long COVID on health and quality of life. HRB Open Res. 2022;5:31. doi: 10.12688/hrbopenres.13516.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/hrbopenres.13516.1</ArticleId><ArticleId IdType="pmc">PMC9440374</ArticleId><ArticleId IdType="pubmed">36101871</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkan M., Dvir A., Zaidenstein R., Keller M., Kagansky D., Hochman C., Koren R. Patient-Reported Outcome Measures After Hospitalization During the COVID-19 Pandemic: A Survey Among COVID-19 and Non-COVID-19 Patients. Int. J. Gen. Med. 2021;14:4829&#x2013;4836. doi: 10.2147/IJGM.S323316.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S323316</ArticleId><ArticleId IdType="pmc">PMC8405220</ArticleId><ArticleId IdType="pubmed">34471377</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.S., Wang Z., Abdel-Mohsen M., Chen X., Montaner L.J. Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: Review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID. J. Leukoc. Biol. 2023;113:236&#x2013;254. doi: 10.1093/jleuko/qiac001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jleuko/qiac001</ArticleId><ArticleId IdType="pubmed">36807444</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidar M.A., Shakkour Z., Reslan M.A., Al-Haj N., Chamoun P., Habashy K., Kaafarani H., Shahjouei S., Farran S.H., Shaito A., et al. SARS-CoV-2 involvement in central nervous system tissue damage. Neural. Regen. Res. 2022;17:1228&#x2013;1239. doi: 10.4103/1673-5374.327323.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.327323</ArticleId><ArticleId IdType="pmc">PMC8643043</ArticleId><ArticleId IdType="pubmed">34782556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch S.M., Guo G., Gibson D.S., Bjourson A.J., Rai T.S. Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease. Cells. 2021;10:3367. doi: 10.3390/cells10123367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123367</ArticleId><ArticleId IdType="pmc">PMC8699414</ArticleId><ArticleId IdType="pubmed">34943875</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D., Jeon H.M., Lee J. Tissue factor links inflammation, thrombosis, and senescence in COVID-19. Sci. Rep. 2022;12:19842. doi: 10.1038/s41598-022-23950-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23950-y</ArticleId><ArticleId IdType="pmc">PMC9673213</ArticleId><ArticleId IdType="pubmed">36400883</ArticleId></ArticleIdList></Reference><Reference><Citation>Adjaye-Gbewonyo D., Vahratian A., Perrine C.G., Bertolli J. Long COVID in Adults: United States, 2022. NCHS Data Brief. 2023;480:1&#x2013;8. doi: 10.15620/cdc:132417.</Citation><ArticleIdList><ArticleId IdType="doi">10.15620/cdc:132417</ArticleId><ArticleId IdType="pubmed">37756137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell V., Hall Dykgraaf S., Kidd M., Goodyear-Smith F. Long COVID and older people. Lancet Healthy Longev. 2022;3:e849&#x2013;e854. doi: 10.1016/S2666-7568(22)00245-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(22)00245-8</ArticleId><ArticleId IdType="pubmed">36480981</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K. Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein-Barr virus and the gut-brain axis. Mol. Psychiatry. 2023;28:4968&#x2013;4976. doi: 10.1038/s41380-023-02161-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02161-5</ArticleId><ArticleId IdType="pmc">PMC11041741</ArticleId><ArticleId IdType="pubmed">37402856</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Frase J., Cho S.M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouraeinejad A. Brain fog as a Long-term Sequela of COVID-19. SN Compr. Clin. Med. 2023;5:9. doi: 10.1007/s42399-022-01352-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01352-5</ArticleId><ArticleId IdType="pmc">PMC9685075</ArticleId><ArticleId IdType="pubmed">36466122</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlick S., Lucio M., Wallukat G., Bartsch A., Skornia A., Hoffmanns J., Szewczykowski C., Schr&#xf6;der T., Raith F., Rogge L., et al. Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue. Int. J. Mol. Sci. 2022;23:13683. doi: 10.3390/ijms232213683.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232213683</ArticleId><ArticleId IdType="pmc">PMC9690863</ArticleId><ArticleId IdType="pubmed">36430175</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl E.J., Yao P.J., Kapogiannis D. Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19. Am. J. Med. 2023;136:824&#x2013;829. doi: 10.1016/j.amjmed.2023.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.03.026</ArticleId><ArticleId IdType="pmc">PMC10106499</ArticleId><ArticleId IdType="pubmed">37072092</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 Spike Protein Be Responsible for Long COVID Syndrome? Mol. Neurobiol. 2022;59:1850&#x2013;1861. doi: 10.1007/s12035-021-02696-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02696-0</ArticleId><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Zhang H., Li W., Zhai J., Li X., Zheng C. The role of SARS-CoV-2 ORF7a in autophagy flux disruption: Implications for viral infection and pathogenesis. Autophagy. 2024:1&#x2013;3. doi: 10.1080/15548627.2024.2312787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2024.2312787</ArticleId><ArticleId IdType="pmc">PMC11210892</ArticleId><ArticleId IdType="pubmed">38361390</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Cruz-Enr&#xed;quez J., Rojas-Morales E., Ru&#xed;z-Garc&#xed;a M.G., Tob&#xf3;n-Velasco J.C., Jim&#xe9;nez-Ortega J.C. SARS-CoV-2 induces mitochondrial dysfunction and cell death by oxidative stress/inflammation in leukocytes of COVID-19 patients. Free Radic. Res. 2021;55:982&#x2013;995. doi: 10.1080/10715762.2021.2005247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715762.2021.2005247</ArticleId><ArticleId IdType="pubmed">34866537</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Wang W., Wang T., Wang J., Jiang Y., Wang X., Qiu Z., Feng N., Sun W., Li C., et al. ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: An Unbiased Study. J. Virol. 2023;97:e0001123. doi: 10.1128/jvi.00011-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00011-23</ArticleId><ArticleId IdType="pmc">PMC10062165</ArticleId><ArticleId IdType="pubmed">36877072</ArticleId></ArticleIdList></Reference><Reference><Citation>Albornoz E.A., Amarilla A.A., Modhiran N., Parker S., Li X.X., Wijesundara D.K., Aguado J., Zamora A.P., McMillan C.L.D., Liang B., et al. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol. Psychiatry. 2023;28:2878&#x2013;2893. doi: 10.1038/s41380-022-01831-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01831-0</ArticleId><ArticleId IdType="pmc">PMC10615762</ArticleId><ArticleId IdType="pubmed">36316366</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q., Hu D., Zheng F., Chen W., Hu K., Liu J., Yao C., Li H., Wei Y. Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies. Viruses. 2024;16:213. doi: 10.3390/v16020213.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16020213</ArticleId><ArticleId IdType="pmc">PMC10892947</ArticleId><ArticleId IdType="pubmed">38399989</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Yu F., Chang W., Zhang Y., Zhang L., Li P. Inflammasomes: A rising star on the horizon of COVID-19 pathophysiology. Front. Immunol. 2023;14:1185233. doi: 10.3389/fimmu.2023.1185233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1185233</ArticleId><ArticleId IdType="pmc">PMC10213254</ArticleId><ArticleId IdType="pubmed">37251383</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna C., Brogna B., Bisaccia D.R., Lauritano F., Marino G., Montano L., Cristoni S., Prisco M., Piscopo M. Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages? Vaccines. 2022;10:708. doi: 10.3390/vaccines10050708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050708</ArticleId><ArticleId IdType="pmc">PMC9143435</ArticleId><ArticleId IdType="pubmed">35632464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Pang X., Wu J., Liu T., Wang B., Cao H. Gut microbiota in COVID-19: New insights from inside. Gut Microbes. 2023;15:2201157. doi: 10.1080/19490976.2023.2201157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2023.2201157</ArticleId><ArticleId IdType="pmc">PMC10120564</ArticleId><ArticleId IdType="pubmed">37078497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n Gim&#xe9;nez V.M., Modrego J., G&#xf3;mez-Garre D., Manucha W., de las Heras N. Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy. Int. J. Mol. Sci. 2023;24:12249. doi: 10.3390/ijms241512249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241512249</ArticleId><ArticleId IdType="pmc">PMC10419057</ArticleId><ArticleId IdType="pubmed">37569625</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenazy M.F., Aljohar H.I., Alruwaili A.R., Daghestani M.H., Alonazi M.A., Labban R.S., El-Ansary A.K., Balto H.A. Gut Microbiota Dynamics in Relation to Long COVID -19 Syndrome: Role of Probiotics to Combat Psychiatric Complications. Metabolites. 2022;12:912. doi: 10.3390/metabo12100912.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12100912</ArticleId><ArticleId IdType="pmc">PMC9611210</ArticleId><ArticleId IdType="pubmed">36295814</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Waltz E. Could long COVID be linked to herpes viruses? Early data offer a hint. Nature. 2022;601:173&#x2013;174. doi: 10.1038/d41586-022-02296-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-02296-5</ArticleId><ArticleId IdType="pubmed">36008721</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S., Kril I., Nadizhko O., Matsyura O., Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: A pilot observational study. Rheumatol. Int. 2022;42:1523&#x2013;1530. doi: 10.1007/s00296-022-05146-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., Saidara E., Maes M. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID. Viruses. 2023;15:400. doi: 10.3390/v15020400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020400</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Berentschot J.C., Drexhage H.A., Aynekulu Mersha D.G., Wijkhuijs A.J.M., Geurtsvan Kessel C.H., Koopmans M.P.G., Voermans J.J.C., Hendriks R.W., Nagtzaam N.M.A., de Bie M., et al. Immunological profiling in long COVID: Overall low-grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity. Front. Immunol. 2023;14:1254899. doi: 10.3389/fimmu.2023.1254899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1254899</ArticleId><ArticleId IdType="pmc">PMC10597688</ArticleId><ArticleId IdType="pubmed">37881427</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Muller S., Kanduc D., David P., Halpert G., Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun. Rev. 2021;20:102792. doi: 10.1016/j.autrev.2021.102792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102792</ArticleId><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan M., Rabaan A.A., Alwarthan S., Alhajri M., Halwani M.A., Alshengeti A., Najim M.A., Alwashmi A.S.S., Alshehri A.A., Alshamrani S.A., et al. Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID. Vaccines. 2023;11:699. doi: 10.3390/vaccines11030699.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030699</ArticleId><ArticleId IdType="pmc">PMC10059134</ArticleId><ArticleId IdType="pubmed">36992283</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E., Sarapultsev A., Solomatina L., Chereshnev V. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Int. J. Mol. Sci. 2022;23:1716. doi: 10.3390/ijms23031716.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031716</ArticleId><ArticleId IdType="pmc">PMC8835786</ArticleId><ArticleId IdType="pubmed">35163638</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobasheri L., Nasirpour M.H., Masoumi E., Azarnaminy A.F., Jafari M., Esmaeili S.A. SARS-CoV-2 triggering autoimmune diseases. Cytokine. 2022;154:155873. doi: 10.1016/j.cyto.2022.155873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2022.155873</ArticleId><ArticleId IdType="pmc">PMC8979824</ArticleId><ArticleId IdType="pubmed">35461172</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi M.C., Tamiazzo S., Stobbione P., Agatea L., De Gaspari P., Stecca A., Lauritano E.C., Roveta A., Tozzoli R., Guaschino R., et al. SARS-CoV-2 infection as a trigger of autoimmune response. Clin. Transl. Sci. 2021;14:898&#x2013;907. doi: 10.1111/cts.12953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12953</ArticleId><ArticleId IdType="pmc">PMC8212749</ArticleId><ArticleId IdType="pubmed">33306235</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K., Li X., Yang D., Chan S.C.W., Zhou J., Wan E.Y.F., Chui C.S.L., Lai F.T.T., Wong C.K.H., Chan E.W.Y., et al. Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: A population-based cohort study. eClinicalMedicine. 2023;63:102154. doi: 10.1016/j.eclinm.2023.102154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102154</ArticleId><ArticleId IdType="pmc">PMC10458663</ArticleId><ArticleId IdType="pubmed">37637754</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., M&#xfc;ller B., Merle U. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin. Infect. Dis. 2022;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Morrone M.C., Patrono C., Santoro M.G., Schiaffino S., Remuzzi G., Bussolati G. Long Covid: Where we stand and challenges ahead. Cell Death Differ. 2022;29:1891&#x2013;1900. doi: 10.1038/s41418-022-01052-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-01052-6</ArticleId><ArticleId IdType="pmc">PMC9449925</ArticleId><ArticleId IdType="pubmed">36071155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutman E.G., Fernandes R.A., Raposo-Vedovi J.V., Salvio A.L., Duarte L.A., Tardim C.F., Costa V.G.C., Pereira V.C.S.R., Bahia P.R.V., da Silva M.M., et al. Molecular Mimicry between SARS-CoV-2 Proteins and Human Self-Antigens Related with Autoimmune Central Nervous System (CNS) Disorders. Microorganisms. 2023;11:2902. doi: 10.3390/microorganisms11122902.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11122902</ArticleId><ArticleId IdType="pmc">PMC10745528</ArticleId><ArticleId IdType="pubmed">38138047</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafon-Hughes L. Towards Understanding Long COVID: SARS-CoV-2 Strikes the Host Cell Nucleus. Pathogens. 2023;12:806. doi: 10.3390/pathogens12060806.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12060806</ArticleId><ArticleId IdType="pmc">PMC10301789</ArticleId><ArticleId IdType="pubmed">37375496</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K., Jamil R., Chowdhury A., Mukherjee M., Venegas C., Miyasaki K., Zhang K., Patel Z., Salter B., Yuen A.C.Y., et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. 2023;61:2200970. doi: 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachoyiannopoulos P.G., Magira E., Alexopoulos H., Jahaj E., Theophilopoulou K., Kotanidou A., Tzioufas A.G. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann. Rheum. Dis. 2020;79:1661&#x2013;1663. doi: 10.1136/annrheumdis-2020-218009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218009</ArticleId><ArticleId IdType="pubmed">32581086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerma L.A., Chaudhary A., Bryan A., Morishima C., Wener M.H., Fink S.L. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19) J. Transl. Autoimmun. 2020;3:100073. doi: 10.1016/j.jtauto.2020.100073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2020.100073</ArticleId><ArticleId IdType="pmc">PMC7691817</ArticleId><ArticleId IdType="pubmed">33263103</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe0; M., Mercad&#xe9;-Besora N., Kolde R., Trinh N.T.H., Roel E., Burn E., Rathod-Mistry T., Kostka K., Man W.Y., Delmestri A., et al. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: Staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir. Med. 2024;12:225&#x2013;236. doi: 10.1016/S2213-2600(23)00414-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00414-9</ArticleId><ArticleId IdType="pubmed">38219763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Kulzhabayeva D., Rodrigues N.B., Di Vincenzo J.D., Gill H., Subramaniapillai M., Lui L.M.W., Cao B., Mansur R.B., Ho R.C., et al. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis. Brain Behav. Immun. 2023;111:211&#x2013;229. doi: 10.1016/j.bbi.2023.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10067136</ArticleId><ArticleId IdType="pubmed">36990297</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Razzaghi H., Forrest C.B., Hirabayashi K., Wu Q., Allen A.J., Rao S., Chen Y., Bunnell H.T., Chrischilles E.A., Cowell L.G., et al. Vaccine Effectiveness Against Long COVID in Children. Pediatrics. 2024;153:e2023064446. doi: 10.1542/peds.2023-064446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-064446</ArticleId><ArticleId IdType="pmc">PMC10979300</ArticleId><ArticleId IdType="pubmed">38225804</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Nemati M., Shahisavandi M., Nemati H., Karimi A., Jafari A., Nasiri S., Mohammadi S.S., Rahimian Z., Bayat H., et al. How does COVID-19 vaccination affect long-COVID symptoms? PLoS ONE. 2024;19:e0296680. doi: 10.1371/journal.pone.0296680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0296680</ArticleId><ArticleId IdType="pmc">PMC10849259</ArticleId><ArticleId IdType="pubmed">38324547</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O., Stehlik P., Clark J., Alcorn K., Glasziou P. Effect of COVID-19 vaccination on long covid: Systematic review. BMJ Med. 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public. Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Seb&#x151;k S., Gyires K. Long COVID and possible preventive options. Inflammopharmacology. 2023;31:2807&#x2013;2817. doi: 10.1007/s10787-023-01204-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01204-1</ArticleId><ArticleId IdType="pmc">PMC10692252</ArticleId><ArticleId IdType="pubmed">37344737</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho K., Park S., Kim E.Y., Koyanagi A., Jacob L., Yon D.K., Lee S.W., Kim M.S., Radua J., Elena D., et al. Immunogenicity of COVID-19 vaccines in patients with diverse health conditions: A comprehensive systematic review. J. Med. Virol. 2022;94:4144&#x2013;4155. doi: 10.1002/jmv.27828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27828</ArticleId><ArticleId IdType="pmc">PMC9347877</ArticleId><ArticleId IdType="pubmed">35567325</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto A., Ji S., Chtarbanova S., Kuraishi T. Editorial: Inflammatory and inflammatory-like responses in insects. Front. Immunol. 2023;18:1184429. doi: 10.3389/fimmu.2023.1184429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1184429</ArticleId><ArticleId IdType="pmc">PMC10152397</ArticleId><ArticleId IdType="pubmed">37143679</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E., Zhuravleva Y. Inflammation: A New Look at an Old Problem. Int. J. Mol. Sci. 2022;23:4596. doi: 10.3390/ijms23094596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23094596</ArticleId><ArticleId IdType="pmc">PMC9100490</ArticleId><ArticleId IdType="pubmed">35562986</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchmann K. Evolution of Innate Immunity: Clues from Invertebrates via Fish to Mammals. Front. Immunol. 2014;5:459. doi: 10.3389/fimmu.2014.00459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00459</ArticleId><ArticleId IdType="pmc">PMC4172062</ArticleId><ArticleId IdType="pubmed">25295041</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E.Y., Zhuravleva Y.A., Zotova N.V. Correlation of the evolution of immunity and inflammation in vertebrates. Biol. Bull. Rev. 2019;9:358&#x2013;372. doi: 10.1134/S2079086419040029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S2079086419040029</ArticleId></ArticleIdList></Reference><Reference><Citation>Zotova N.V., Chereshnev V.A., Gusev E.Y. Systemic Inflammation: Methodological Approaches to Identification of the Common Pathological Process. PLoS ONE. 2016;11:e0155138. doi: 10.1371/journal.pone.0155138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155138</ArticleId><ArticleId IdType="pmc">PMC4859514</ArticleId><ArticleId IdType="pubmed">27153324</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazhnikov A., Zotova N., Solomatina L., Sarapultsev A., Spirin A., Gusev E. Shock-Associated Systemic Inflammation in Amniotic Fluid Embolism, Complicated by Clinical Death. Pathophysiology. 2023;30:48&#x2013;62. doi: 10.3390/pathophysiology30010006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathophysiology30010006</ArticleId><ArticleId IdType="pmc">PMC10058189</ArticleId><ArticleId IdType="pubmed">36976733</ArticleId></ArticleIdList></Reference><Reference><Citation>Zotova N., Zhuravleva Y., Chereshnev V., Gusev E. Acute and Chronic Systemic Inflammation: Features and Differences in the Pathogenesis, and Integral Criteria for Verification and Differentiation. Int. J. Mol. Sci. 2023;24:1144. doi: 10.3390/ijms24021144.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021144</ArticleId><ArticleId IdType="pmc">PMC9862412</ArticleId><ArticleId IdType="pubmed">36674657</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E.Y., Zotova N.V., Chereshnev V.A. Sepsis-3: New edition&#x2014;old problems. Analysis from the perspective of general pathology. Russ. J. Infect. Immun. 2021;11:649&#x2013;662. doi: 10.15789/2220-7619-SAN-1629.</Citation><ArticleIdList><ArticleId IdType="doi">10.15789/2220-7619-SAN-1629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ippoliti F., Canitano N., Businaro R. Stress and obesity as risk factors in cardiovascular diseases: A neuroimmune perspective. J. Neuroimmune Pharmacol. 2013;8:212&#x2013;226. doi: 10.1007/s11481-012-9432-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-012-9432-6</ArticleId><ArticleId IdType="pubmed">23329173</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo S., Kwiatkowski M., Govorukhina N., Bischoff R., Melgert B.N. Meta-Inflammation and Metabolic Reprogramming of Macrophages in Diabetes and Obesity: The Importance of Metabolites. Front. Immunol. 2021;12:746151. doi: 10.3389/fimmu.2021.746151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746151</ArticleId><ArticleId IdType="pmc">PMC8602812</ArticleId><ArticleId IdType="pubmed">34804028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar D., Shankar K., Patel S., Gupta A., Varshney S., Gupta S., Rajan S., Srivastava A., Vishwakarma A.L., Gaikwad A.N. Chronic hyperinsulinemia promotes meta-inflammation and extracellular matrix deposition in adipose tissue: Implications of nitric oxide. Mol. Cell Endocrinol. 2018;477:15&#x2013;28. doi: 10.1016/j.mce.2018.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2018.05.010</ArticleId><ArticleId IdType="pubmed">29753026</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T., Larbi A., Dupuis G., Le Page A., Frost E.H., Cohen A.A., Witkowski J.M., Franceschi C. Immunosenescence and Inflamm-Aging as Two Sides of the Same Coin: Friends or Foes? Front. Immunol. 2018;8:1960. doi: 10.3389/fimmu.2017.01960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01960</ArticleId><ArticleId IdType="pmc">PMC5767595</ArticleId><ArticleId IdType="pubmed">29375577</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R.J., Wang E.K., Benayoun B.A. Functional genomics of inflamm-aging and immunosenescence. Brief Funct. Genomics. 2022;21:43&#x2013;55. doi: 10.1093/bfgp/elab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bfgp/elab009</ArticleId><ArticleId IdType="pmc">PMC8789293</ArticleId><ArticleId IdType="pubmed">33690792</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetrani C., Di Nisio A., Paschou S.A., Barrea L., Muscogiuri G., Graziadio C., Savastano S., Colao A. On Behalf of The Obesity Programs of Nutrition Education Research and Assessment Opera Group. From Gut Microbiota through Low-Grade Inflammation to Obesity: Key Players and Potential Targets. Nutrients. 2022;14:2103. doi: 10.3390/nu14102103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14102103</ArticleId><ArticleId IdType="pmc">PMC9145366</ArticleId><ArticleId IdType="pubmed">35631244</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R., Walker A.K. Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J. Neural Transm. 2014;121:925&#x2013;932. doi: 10.1007/s00702-014-1187-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-014-1187-1</ArticleId><ArticleId IdType="pmc">PMC4134384</ArticleId><ArticleId IdType="pubmed">24633997</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E., Sarapultsev A. Interplay of G-Proteins and Serotonin in the Neuroimmunoinflammatory Model of Chronic Stress and Depression: A Narrative Review. Curr. Pharm. Des. 2024;30:180&#x2013;214. doi: 10.2174/0113816128285578231218102020.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0113816128285578231218102020</ArticleId><ArticleId IdType="pubmed">38151838</ArticleId></ArticleIdList></Reference><Reference><Citation>Sublette M.E., Postolache T.T. Neuroinflammation and depression: The role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway. Psychosom. Med. 2012;74:668&#x2013;672. doi: 10.1097/PSY.0b013e318268de9f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0b013e318268de9f</ArticleId><ArticleId IdType="pubmed">22923699</ArticleId></ArticleIdList></Reference><Reference><Citation>Rantala M.J., Luoto S., Borr&#xe1;z-Le&#xf3;n J.I., Krams I. Schizophrenia: The new etiological synthesis. Neurosci. Biobehav. Rev. 2022;142:104894. doi: 10.1016/j.neubiorev.2022.104894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2022.104894</ArticleId><ArticleId IdType="pubmed">36181926</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahed G., Aoun L., Bou Zerdan M., Allam S., Bou Zerdan M., Bouferraa Y., Assi H.I. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci. 2022;23:786. doi: 10.3390/ijms23020786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020786</ArticleId><ArticleId IdType="pmc">PMC8775991</ArticleId><ArticleId IdType="pubmed">35054972</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson W.H., Lepus C.M., Wang Q., Raghu H., Mao R., Lindstrom T.M., Sokolove J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 2016;12:580&#x2013;592. doi: 10.1038/nrrheum.2016.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.136</ArticleId><ArticleId IdType="pmc">PMC5500215</ArticleId><ArticleId IdType="pubmed">27539668</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;nnb&#xe4;ck C., Hansson E. The Importance and Control of Low-Grade Inflammation Due to Damage of Cellular Barrier Systems That May Lead to Systemic Inflammation. Front. Neurol. 2019;10:533. doi: 10.3389/fneur.2019.00533.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00533</ArticleId><ArticleId IdType="pmc">PMC6549124</ArticleId><ArticleId IdType="pubmed">31191433</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E.Y., Zotova N.V., Zhuravleva Y.A., Chereshnev V.A. Physiological and Pathogenic Role of Scavenger Receptors in Humans. Med. Immunol. 2020;22:7&#x2013;48. doi: 10.15789/1563-0625-PAP-1893.</Citation><ArticleIdList><ArticleId IdType="doi">10.15789/1563-0625-PAP-1893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel P., Kossmann S., M&#xfc;nzel T., Daiber A. Redox regulation of cardiovascular inflammation&#x2014;Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species. Free Radic. Biol. Med. 2017;109:48&#x2013;60. doi: 10.1016/j.freeradbiomed.2017.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.01.027</ArticleId><ArticleId IdType="pubmed">28108279</ArticleId></ArticleIdList></Reference><Reference><Citation>Daiber A., Steven S., Vujacic-Mirski K., Kalinovic S., Oelze M., Di Lisa F., M&#xfc;nzel T. Regulation of Vascular Function and Inflammation via Cross Talk of Reactive Oxygen and Nitrogen Species from Mitochondria or NADPH Oxidase-Implications for Diabetes Progression. Int. J. Mol. Sci. 2020;21:3405. doi: 10.3390/ijms21103405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103405</ArticleId><ArticleId IdType="pmc">PMC7279344</ArticleId><ArticleId IdType="pubmed">32408480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassini-Vieira P., Ara&#xfa;jo F.A., da Costa Dias F.L., Russo R.C., Andrade S.P., Teixeira M.M., Barcelos L.S. iNOS Activity Modulates Inflammation, Angiogenesis, and Tissue Fibrosis in Polyether-Polyurethane Synthetic Implants. Mediat. Inflamm. 2015;2015:138461. doi: 10.1155/2015/138461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/138461</ArticleId><ArticleId IdType="pmc">PMC4461775</ArticleId><ArticleId IdType="pubmed">26106257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauwels A. Nitric oxide in shock. Kidney Int. 2007;72:557&#x2013;565. doi: 10.1038/sj.ki.5002340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002340</ArticleId><ArticleId IdType="pubmed">17538569</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E., Sarapultsev A. Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes. Int. J. Mol. Sci. 2023;24:7910. doi: 10.3390/ijms24097910.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24097910</ArticleId><ArticleId IdType="pmc">PMC10178362</ArticleId><ArticleId IdType="pubmed">37175617</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou A.G., Vrettou C.S., Keskinidou C., Dimopoulou I., Kotanidou A., Orfanos S.E. Endotheliopathy in Acute COVID-19 and Long COVID. Int. J. Mol. Sci. 2023;24:8237. doi: 10.3390/ijms24098237.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098237</ArticleId><ArticleId IdType="pmc">PMC10179170</ArticleId><ArticleId IdType="pubmed">37175942</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauricio D., Gratac&#xf2;s M., Franch-Nadal J. Diabetic microvascular disease in non-classical beds: The hidden impact beyond the retina, the kidney, and the peripheral nerves. Cardiovasc. Diabetol. 2023;22:314. doi: 10.1186/s12933-023-02056-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-023-02056-3</ArticleId><ArticleId IdType="pmc">PMC10652502</ArticleId><ArticleId IdType="pubmed">37968679</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L., Engedal T.S., Moreton F., Hansen M.B., Wardlaw J.M., Dalkara T., Markus H.S., Muir K.W. Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline. J. Cereb. Blood Flow. Metab. 2016;36:302&#x2013;325. doi: 10.1177/0271678X15606723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X15606723</ArticleId><ArticleId IdType="pmc">PMC4759673</ArticleId><ArticleId IdType="pubmed">26661176</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomanek R.J. The coronary capillary bed and its role in blood flow and oxygen delivery: A review. Anat. Rec. 2022;305:3199&#x2013;3211. doi: 10.1002/ar.24951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.24951</ArticleId><ArticleId IdType="pmc">PMC9796134</ArticleId><ArticleId IdType="pubmed">35521832</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E., Solomatina L., Zhuravleva Y., Sarapultsev A. The Pathogenesis of End-Stage Renal Disease from the Standpoint of the Theory of General Pathological Processes of Inflammation. Int. J. Mol. Sci. 2021;22:11453. doi: 10.3390/ijms222111453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111453</ArticleId><ArticleId IdType="pmc">PMC8584056</ArticleId><ArticleId IdType="pubmed">34768884</ArticleId></ArticleIdList></Reference><Reference><Citation>Scanzello C.R. Role of low-grade inflammation in osteoarthritis. Curr. Opin. Rheumatol. 2017;29:79&#x2013;85. doi: 10.1097/BOR.0000000000000353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000353</ArticleId><ArticleId IdType="pmc">PMC5565735</ArticleId><ArticleId IdType="pubmed">27755180</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., Gorl&#xe9; N., Vandendriessche C., Van Imschoot G., Van Wonterghem E., Van Cauwenberghe C., Parthoens E., Van Hamme E., Lippens S., Van Hoecke L., et al. Low-grade peripheral inflammation affects brain pathology in the AppNL-G-Fmouse model of Alzheimer&#x2019;s disease. Acta. Neuropathol. Commun. 2021;9:163. doi: 10.1186/s40478-021-01253-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01253-z</ArticleId><ArticleId IdType="pmc">PMC8499584</ArticleId><ArticleId IdType="pubmed">34620254</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker K.A. Inflammation and neurodegeneration: Chronicity matters. Aging. 2018;11:3&#x2013;4. doi: 10.18632/aging.101704.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101704</ArticleId><ArticleId IdType="pmc">PMC6339781</ArticleId><ArticleId IdType="pubmed">30554190</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Xiao D., Mao Q., Xia H. Role of neuroinflammation in neurodegeneration development. Signal. Transduct. Target Ther. 2023;8:267. doi: 10.1038/s41392-023-01486-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01486-5</ArticleId><ArticleId IdType="pmc">PMC10336149</ArticleId><ArticleId IdType="pubmed">37433768</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzl F.A., Ambrosini S., Mohammed S.A., Kraler S., L&#xfc;scher T.F., Costantino S., Paneni F. Inflammation in Metabolic Cardiomyopathy. Front. Cardiovasc. Med. 2021;8:742178. doi: 10.3389/fcvm.2021.742178.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.742178</ArticleId><ArticleId IdType="pmc">PMC8520939</ArticleId><ArticleId IdType="pubmed">34671656</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecoro G., Annunziata M., Iuorio M.T., Nastri L., Guida L. Periodontitis, Low-Grade Inflammation and Systemic Health: A Scoping Review. Medicina. 2020;56:272. doi: 10.3390/medicina56060272.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina56060272</ArticleId><ArticleId IdType="pmc">PMC7353850</ArticleId><ArticleId IdType="pubmed">32486269</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Liu S., Leng S.X. Chronic Low-grade Inflammatory Phenotype (CLIP) and Senescent Immune Dysregulation. Clin. Ther. 2019;41:400&#x2013;409. doi: 10.1016/j.clinthera.2019.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.02.001</ArticleId><ArticleId IdType="pubmed">30833113</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E.Y., Zotova N.V. Cellular Stress and General Pathological Processes. Curr Pharm Des. 2019;25:251&#x2013;297. doi: 10.2174/1381612825666190319114641.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612825666190319114641</ArticleId><ArticleId IdType="pubmed">31198111</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X., Meng G. Inflammasomes in the Gut Mucosal Homeostasis. Adv. Exp. Med. Biol. 2017;1024:133&#x2013;151. doi: 10.1007/978-981-10-5987-2_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-10-5987-2_6</ArticleId><ArticleId IdType="pubmed">28921468</ArticleId></ArticleIdList></Reference><Reference><Citation>Moutsopoulos N.M., Madianos P.N. Low-grade inflammation in chronic infectious diseases: Paradigm of periodontal infections. Ann. N. Y. Acad. Sci. 2006;1088:251&#x2013;264. doi: 10.1196/annals.1366.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1366.032</ArticleId><ArticleId IdType="pubmed">17192571</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinh Q.D. Recent Research in Cell Stress and Microbial Infection. Microorganisms. 2022;10:622. doi: 10.3390/microorganisms10030622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10030622</ArticleId><ArticleId IdType="pmc">PMC8951272</ArticleId><ArticleId IdType="pubmed">35336195</ArticleId></ArticleIdList></Reference><Reference><Citation>Valad&#xe3;o A.L., Aguiar R.S., de Arruda L.B. Interplay between Inflammation and Cellular Stress Triggered by Flaviviridae Viruses. Front. Microbiol. 2016;7:1233. doi: 10.3389/fmicb.2016.01233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.01233</ArticleId><ArticleId IdType="pmc">PMC4996823</ArticleId><ArticleId IdType="pubmed">27610098</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Y., Wang Y., Fu X., Bai G., Li X., Mao J., Yan Y., Hu L. Multiple functions of stress granules in viral infection at a glance. Front. Microbiol. 2023;14:1138864. doi: 10.3389/fmicb.2023.1138864.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1138864</ArticleId><ArticleId IdType="pmc">PMC10014870</ArticleId><ArticleId IdType="pubmed">36937261</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Q., Song D., Li H., He M.L. Stress proteins: The biological functions in virus infection, present and challenges for target-based antiviral drug development. Signal Transduct. Target. Ther. 2020;5:125. doi: 10.1038/s41392-020-00233-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00233-4</ArticleId><ArticleId IdType="pmc">PMC7356129</ArticleId><ArticleId IdType="pubmed">32661235</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo J., Bellot G., Pervaiz S., Alonso S. Mitochondria-mediated oxidative stress during viral infection. Trends Microbiol. 2022;30:679&#x2013;692. doi: 10.1016/j.tim.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.12.011</ArticleId><ArticleId IdType="pubmed">35063304</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad V., Greber U.F. The endoplasmic reticulum unfolded protein response&#x2014;Homeostasis, cell death and evolution in virus infections. FEMS Microbiol. Rev. 2021;45:fuab016. doi: 10.1093/femsre/fuab016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fuab016</ArticleId><ArticleId IdType="pmc">PMC8498563</ArticleId><ArticleId IdType="pubmed">33765123</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrbod P., Ande S.R., Alizadeh J., Rahimizadeh S., Shariati A., Malek H., Hashemi M., Glover K.K.M., Sher A.A., Coombs K.M., et al. The roles of apoptosis, autophagy, and unfolded protein response in arbovirus, influenza virus, and HIV infections. Virulence. 2019;10:376&#x2013;413. doi: 10.1080/21505594.2019.1605803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2019.1605803</ArticleId><ArticleId IdType="pmc">PMC6527025</ArticleId><ArticleId IdType="pubmed">30966844</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioia U., Tavella S., Mart&#xed;nez-Orellana P., Cicio G., Colliva A., Ceccon M., Cabrini M., Henriques A.C., Fumagalli V., Paldino A., et al. SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence. Nat. Cell Biol. 2023;25:550&#x2013;564. doi: 10.1038/s41556-023-01096-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-023-01096-x</ArticleId><ArticleId IdType="pmc">PMC10104783</ArticleId><ArticleId IdType="pubmed">36894671</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Garcia P., Fiorillo Moreno O., Zarate Pe&#xf1;ata E., Calderon-Villalba A., Pacheco Lugo L., Acosta Hoyos A., Villarreal Camacho J.L., Navarro Quiroz R., Pacheco Londo&#xf1;o L., Aroca Martinez G., et al. From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID. Int. J. Mol. Sci. 2023;24:8290. doi: 10.3390/ijms24098290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098290</ArticleId><ArticleId IdType="pmc">PMC10179575</ArticleId><ArticleId IdType="pubmed">37175995</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E., Sarapultsev A., Hu D., Chereshnev V. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes) Int. J. Mol. Sci. 2021;22:7582. doi: 10.3390/ijms22147582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22147582</ArticleId><ArticleId IdType="pmc">PMC8304657</ArticleId><ArticleId IdType="pubmed">34299201</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Reyes A., Villegas-Valverde C.A. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology. MEDICC Rev. 2021;23:42. doi: 10.37757/MR2021.V23.N2.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.37757/MR2021.V23.N2.4</ArticleId><ArticleId IdType="pubmed">33974614</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappetta S., Sharma A.M., Bottino V., Stier C. COVID-19 and the role of chronic inflammation in patients with obesity. Int. J. Obes. 2020;44:1790&#x2013;1792. doi: 10.1038/s41366-020-0597-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-020-0597-4</ArticleId><ArticleId IdType="pmc">PMC7224343</ArticleId><ArticleId IdType="pubmed">32409680</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscogiuri G., Bettini S., Boschetti M., Barrea L., Savastano S., Colao A. Obesity Programs of nutrition, education, research and evaluation (OPERA) group. Low-grade inflammation, COVID-19, and obesity: Clinical aspects and molecular insights in childhood and adulthood. Int. J. Obes. 2022;46:1254&#x2013;1261. doi: 10.1038/s41366-022-01111-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-022-01111-5</ArticleId><ArticleId IdType="pmc">PMC8988546</ArticleId><ArticleId IdType="pubmed">35393519</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv B., Huang S., Huang H., Niu N., Liu J. Endothelial Glycocalyx Injury in SARS-CoV-2 Infection: Molecular Mechanisms and Potential Targeted Therapy. Mediat. Inflamm. 2023;2023:6685251. doi: 10.1155/2023/6685251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/6685251</ArticleId><ArticleId IdType="pmc">PMC10480029</ArticleId><ArticleId IdType="pubmed">37674786</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S.W., Ilyas I., Weng J.P. Endothelial dysfunction in COVID-19: An overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol. Sin. 2023;44:695&#x2013;709. doi: 10.1038/s41401-022-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L., Benigni A., Remuzzi G. SARS-CoV-2 and the spike protein in endotheliopathy. Trends Microbiol. 2024;32:53&#x2013;67. doi: 10.1016/j.tim.2023.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2023.06.004</ArticleId><ArticleId IdType="pmc">PMC10258582</ArticleId><ArticleId IdType="pubmed">37393180</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi A.A., Kathuria A., Al Mahmeed W., Al-Rasadi K., Al-Alawi K., Banach M., Banerjee Y., Ceriello A., Cesur M., Cosentino F., et al. Cardiometabolic Panel of International experts on Syndemic COVID-19 (CAPISCO). Post-COVID syndrome, inflammation, and diabetes. J. Diabetes Complicat. 2022;36:108336. doi: 10.1016/j.jdiacomp.2022.108336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2022.108336</ArticleId><ArticleId IdType="pmc">PMC9534783</ArticleId><ArticleId IdType="pubmed">36228563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Mart&#xed;nez M.M., Carrera Boada C., Madera-Silva M.D., Mar&#xed;n W., Contreras M. COVID-19 and diabetes: A bidirectional relationship. Clin. Investig. Arterioscler. 2021;33:151&#x2013;157. doi: 10.1016/j.arteri.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arteri.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7598432</ArticleId><ArticleId IdType="pubmed">33303218</ArticleId></ArticleIdList></Reference><Reference><Citation>Faruqi J., Balasubramanyam A. COVID-19 and diabetes mellitus: A review of the incidence, pathophysiology and management of diabetes during the pandemic. Expert. Rev. Endocrinol. Metab. 2023;18:167&#x2013;179. doi: 10.1080/17446651.2023.2176300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17446651.2023.2176300</ArticleId><ArticleId IdType="pubmed">36797835</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n E., Yang C., Shannon C.P., Assadian S., He D., Tebbutt S.J. Cellular and molecular biomarkers of long COVID: A scoping review. eBioMedicine. 2023;91:104552. doi: 10.1016/j.ebiom.2023.104552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Xiang M., Jing H., Wang C., Novakovic V.A., Shi J. Damage to endothelial barriers and its contribution to long COVID. Angiogenesis. 2024;27:5&#x2013;22. doi: 10.1007/s10456-023-09878-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-023-09878-5</ArticleId><ArticleId IdType="pmc">PMC10134732</ArticleId><ArticleId IdType="pubmed">37103631</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I., Schulze A., Evers G., Harmening K., Vink H., K&#xfc;mpers P., Mohr M., Rovas A. Persistent capillary rarefaction in long COVID syndrome. Angiogenesis. 2023;26:53&#x2013;61. doi: 10.1007/s10456-022-09850-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained post-acute infection syndromes. Nat. Med. 2022;28:911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallmach A., Quickert S., Puta C., Reuken P.A. The gastrointestinal microbiota in the development of ME/CFS: A critical view and potential perspectives. Front. Immunol. 2024;15:1352744. doi: 10.3389/fimmu.2024.1352744.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1352744</ArticleId><ArticleId IdType="pmc">PMC11007072</ArticleId><ArticleId IdType="pubmed">38605969</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C., Yi B., Wu J., Lu J. The microbiome in post-acute infection syndrome (PAIS) Comput. Struct. Biotechnol. J. 2023;21:3904&#x2013;3911. doi: 10.1016/j.csbj.2023.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2023.08.002</ArticleId><ArticleId IdType="pmc">PMC10432703</ArticleId><ArticleId IdType="pubmed">37602232</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallek M., Adorjan K., Behrends U., Ertl G., Suttorp N., Lehmann C. Post-COVID Syndrome. Dtsch. Arztebl. Int. 2023;120:48&#x2013;55. doi: 10.3238/arztebl.m2022.0409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0409</ArticleId><ArticleId IdType="pmc">PMC10060997</ArticleId><ArticleId IdType="pubmed">36633452</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A., Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect. Dis. 2023;23:393&#x2013;395. doi: 10.1016/S1473-3099(23)00053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Levinson W., Chin-Hong P., Joyce E.A., Nussbaum J., Schwartz B. Review of Medical Microbiology &amp; Immunology: A Guide to Clinical Infectious Diseases. 16th ed. McGraw Hill; New York, NY, USA: 2020. Slow Viruses &amp; Prions.</Citation></Reference><Reference><Citation>Persaud D., Zhou Y., Siliciano J.M., Siliciano R.F. Latency in human immunodeficiency virus type 1 infection: No easy answers. J. Virol. 2003;77:1659&#x2013;1665. doi: 10.1128/jvi.77.3.1659-1665.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.77.3.1659-1665.2003</ArticleId><ArticleId IdType="pmc">PMC140995</ArticleId><ArticleId IdType="pubmed">12525599</ArticleId></ArticleIdList></Reference><Reference><Citation>Doorbar J. The human Papillomavirus twilight zone&#x2014;Latency, immune control and subclinical infection. Tumor Virus Res. 2023;16:200268. doi: 10.1016/j.tvr.2023.200268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tvr.2023.200268</ArticleId><ArticleId IdType="pmc">PMC10774944</ArticleId><ArticleId IdType="pubmed">37354969</ArticleId></ArticleIdList></Reference><Reference><Citation>Marusawa H., Uemoto S., Hijikata M., Ueda Y., Tanaka K., Shimotohno K., Chiba T. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology. 2000;31:488&#x2013;495. doi: 10.1002/hep.510310232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.510310232</ArticleId><ArticleId IdType="pubmed">10655275</ArticleId></ArticleIdList></Reference><Reference><Citation>Odenwald M.A., Paul S. Viral hepatitis: Past, present, and future. World J. Gastroenterol. 2022;28:1405&#x2013;1429. doi: 10.3748/wjg.v28.i14.1405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v28.i14.1405</ArticleId><ArticleId IdType="pmc">PMC9048475</ArticleId><ArticleId IdType="pubmed">35582678</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends. Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S., Zhao Y., Zeng N., Liu X., Zheng Y., Sun J., Zhong Y., Wu S., Ni S., Gong Y., et al. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: An update. Mol. Psychiatry. 2023;28:4056&#x2013;4069. doi: 10.1038/s41380-023-02171-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02171-3</ArticleId><ArticleId IdType="pubmed">37491461</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M., Tate M., Lloyd O., Maraolo A.E., Schafers J., Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: A systematic review and meta-analysis. Lancet Microbe. 2021;2:e13&#x2013;e22. doi: 10.1016/S2666-5247(20)30172-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30172-5</ArticleId><ArticleId IdType="pmc">PMC7837230</ArticleId><ArticleId IdType="pubmed">33521734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Zhang Z., Zhou J., Han S., Kang Z., Chuang H., Fan H., Zhao H., Wang L., Ning Y., et al. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients with Neurological Manifestations. Front. Immunol. 2021;12:782731. doi: 10.3389/fimmu.2021.782731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.782731</ArticleId><ArticleId IdType="pmc">PMC8695435</ArticleId><ArticleId IdType="pubmed">34956212</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang T.T.T., Anzurez A., Nakayama-Hosoya K., Miki S., Yamashita K., de Souza M., Matano T., Kawana-Tachikawa A. Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19. Microbiol. Spectr. 2023;11:e0214323. doi: 10.1128/spectrum.02143-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02143-23</ArticleId><ArticleId IdType="pmc">PMC10433967</ArticleId><ArticleId IdType="pubmed">37428088</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B.A., Lim E.Y., Mactavous L., NIHR BioResource Team. Lyons P.A., Doffinger R., Bradley J.R., Smith K.G.C., Sinclair J., Matheson N.J., et al. Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID. EBioMedicine. 2022;81:104129. doi: 10.1016/j.ebiom.2022.104129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104129</ArticleId><ArticleId IdType="pmc">PMC9235296</ArticleId><ArticleId IdType="pubmed">35772216</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh K., Larsen T.G., Hansen C.B., Hasselbalch R.B., Eriksen A.R.R., Bundgaard H., Frikke-Schmidt R., Hilsted L.M., &#xd8;stergaard L., Johansen I.S., et al. Self-Reported Long COVID and Its Association with the Presence of SARS-CoV-2 Antibodies in a Danish Cohort up to 12 Months after Infection. Microbiol. Spectr. 2022;10:e0253722. doi: 10.1128/spectrum.02537-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02537-22</ArticleId><ArticleId IdType="pmc">PMC9769646</ArticleId><ArticleId IdType="pubmed">36350150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kervevan J., Staropoli I., Slama D., Jeger-Madiot R., Donnadieu F., Planas D., Pietri M.P., Loghmari-Bouchneb W., Alaba Tanah M., Robinot R., et al. Divergent adaptive immune responses define two types of long COVID. Front. Immunol. 2023;14:1221961. doi: 10.3389/fimmu.2023.1221961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1221961</ArticleId><ArticleId IdType="pmc">PMC10408302</ArticleId><ArticleId IdType="pubmed">37559726</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J.R., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Haunhorst S., Bloch W., Javelle F., Kr&#xfc;ger K., Baumgart S., Drube S., Lemh&#xf6;fer C., Reuken P., Stallmach A., M&#xfc;ller M., et al. A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients&#x2014;Indications for their potential involvement in the development of long-term COVID? Front. Immunol. 2022;13:1070994. doi: 10.3389/fimmu.2022.1070994.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1070994</ArticleId><ArticleId IdType="pmc">PMC9792979</ArticleId><ArticleId IdType="pubmed">36582234</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheb Sharif-Askari F., Ali Hussain Alsayed H., Tleyjeh I., Saheb Sharif-Askari N., Al Sayed Hussain A., Saddik B., Hamid Q., Halwani R. Sotrovimab Lowers the Risk of COVID-19 Related Hospitalization or Death in a Large Population Cohort in the United Arab Emirates. Clin. Pharmacol. Ther. 2022;112:1214&#x2013;1223. doi: 10.1002/cpt.2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2700</ArticleId><ArticleId IdType="pmc">PMC9349865</ArticleId><ArticleId IdType="pubmed">35780295</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.Y., Whalley J.P., Knight J.C., Wicker L.S., Todd J.A., Ferreira R.C. SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile. Genome Med. 2023;15:69. doi: 10.1186/s13073-023-01227-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-023-01227-x</ArticleId><ArticleId IdType="pmc">PMC10498514</ArticleId><ArticleId IdType="pubmed">37700317</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y.J., Liu S.H., Manachevakul S., Lee T.A., Kuo C.T., Bello D. Biomarkers in long COVID-19: A systematic review. Front. Med. 2023;10:1085988. doi: 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sar&#x131;&#xe7;am E., Dursun A.D., T&#xfc;rkmen Sar&#x131;y&#x131;ld&#x131;z G., Can N., Bozkurt E., G&#xf6;n&#xfc;ll&#xfc; U., Basay N., T&#xfc;rkmen M., Denli A., &#xdc;nl&#xfc; M. Laboratory and Imaging Evaluation of Cardiac Involvement in Patients with Post-Acute COVID-19. Int. J. Gen. Med. 2021;14:4977&#x2013;4985. doi: 10.2147/IJGM.S321156.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S321156</ArticleId><ArticleId IdType="pmc">PMC8412825</ArticleId><ArticleId IdType="pubmed">34511982</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes S.M.R., Brito A.C.S., Manfro W.F.P., Ribeiro-Alves M., Ribeiro R.S.A., da Cal M.S., Lisboa V.D.C., Abreu D.P.B., Castilho L.D.R., Porto L.C.M.S., et al. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-term-COVID-19 patients. PLoS ONE. 2023;18:e0283983. doi: 10.1371/journal.pone.0283983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0283983</ArticleId><ArticleId IdType="pmc">PMC10075475</ArticleId><ArticleId IdType="pubmed">37018291</ArticleId></ArticleIdList></Reference><Reference><Citation>Low R.N., Low R.J., Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front. Med. 2023;10:1011936. doi: 10.3389/fmed.2023.1011936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumantri S., Rengganis I. Immunological dysfunction and mast cell activation syndrome in long COVID. Asia Pac. Allergy. 2023;13:50&#x2013;53. doi: 10.5415/apallergy.0000000000000022.</Citation><ArticleIdList><ArticleId IdType="doi">10.5415/apallergy.0000000000000022</ArticleId><ArticleId IdType="pmc">PMC10166245</ArticleId><ArticleId IdType="pubmed">37389095</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M., Artime A., Pariente E., Fierro P., Ruiz Y., Guti&#xe9;rrez S., Tobalina M., D&#xed;az-Salazar S., Ramos C., Olmos J.M., et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: A cross-sectional study. Curr. Med. Res. Opin. 2022;38:901&#x2013;909. doi: 10.1080/03007995.2022.2042991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2042991</ArticleId><ArticleId IdType="pmc">PMC8935459</ArticleId><ArticleId IdType="pubmed">35166141</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A., Vasaikar S.V., Szeto G.L., Lemos M.P., Czartoski J.L., MacMillan H., Moodie Z., Cohen K.W., Fleming L.B., Thomson Z., et al. Persistent serum protein signatures define an inflammatory subcategory of long COVID. Nat. Commun. 2023;14:3417. doi: 10.1038/s41467-023-38682-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38682-4</ArticleId><ArticleId IdType="pmc">PMC10252177</ArticleId><ArticleId IdType="pubmed">37296110</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlandson K.M., Campbell T.B. Inflammation in Chronic HIV Infection: What Can We Do? J. Infect. Dis. 2015;212:339&#x2013;342. doi: 10.1093/infdis/jiv007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv007</ArticleId><ArticleId IdType="pubmed">25583171</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe S.M., Westhorpe C.L., Mukhamedova N., Jaworowski A., Sviridov D., Bukrinsky M. The macrophage: The intersection between HIV infection and atherosclerosis. J. Leukoc. Biol. 2010;87:589&#x2013;598. doi: 10.1189/jlb.0809580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0809580</ArticleId><ArticleId IdType="pmc">PMC3085483</ArticleId><ArticleId IdType="pubmed">19952353</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen O. A characterization of low-grade inflammation and metabolic complications in HIV-infected patients. Dan. Med. J. 2016;63:B5291.</Citation><ArticleIdList><ArticleId IdType="pubmed">27697134</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgeois C., Gorwood J., Olivo A., Le Pelletier L., Capeau J., Lambotte O., B&#xe9;r&#xe9;ziat V., Lagathu C. Contribution of Adipose Tissue to the Chronic Immune Activation and Inflammation Associated with HIV Infection and Its Treatment. Front. Immunol. 2021;12:670566. doi: 10.3389/fimmu.2021.670566.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.670566</ArticleId><ArticleId IdType="pmc">PMC8250865</ArticleId><ArticleId IdType="pubmed">34220817</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerville F., Vialemaringe M., Cognet C., Duffau P., Lazaro E., Cazanave C., Bonnet F., Leleux O., Rossignol R., Pinson B., et al. Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: The inflammasome hypothesis. AIDS. 2023;37:1035&#x2013;1046. doi: 10.1097/QAD.0000000000003546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000003546</ArticleId><ArticleId IdType="pubmed">36928274</ArticleId></ArticleIdList></Reference><Reference><Citation>Eastburn A., Scherzer R., Zolopa A.R., Benson C., Tracy R., Do T., Bacchetti P., Shlipak M., Grunfeld C., Tien P.C. Association of low-level viremia with inflammation and mortality in HIV-infected adults. PLoS ONE. 2011;6:e26320. doi: 10.1371/journal.pone.0026320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026320</ArticleId><ArticleId IdType="pmc">PMC3206804</ArticleId><ArticleId IdType="pubmed">22073156</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanser S., Mphekgwana P.M., Moraba M.M., Erasmus L., van Staden M. Increased endothelial biomarkers are associated with HIV antiretroviral therapy and C-reactive protein among an African rural population in Limpopo Province, South Africa. Front. Public Health. 2022;10:980754. doi: 10.3389/fpubh.2022.980754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.980754</ArticleId><ArticleId IdType="pmc">PMC9672841</ArticleId><ArticleId IdType="pubmed">36407976</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh R.V., Ma Y., Scherzer R., Heringer A.S., Macgregor J.S., Martin J.N., Deeks S.G., Ganz P., Hsue P.Y. Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection. PLoS ONE. 2016;11:e0146355. doi: 10.1371/journal.pone.0146355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0146355</ArticleId><ArticleId IdType="pmc">PMC4709102</ArticleId><ArticleId IdType="pubmed">26752193</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Underwood M., Llibre J.M., Bernal Morell E., Brinson C., Sanz Moreno J., Scholten S., Moore R., Saggu P., Oyee J., et al. Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study. Open Forum Infect. Dis. 2023;11:ofad626. doi: 10.1093/ofid/ofad626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad626</ArticleId><ArticleId IdType="pmc">PMC10783236</ArticleId><ArticleId IdType="pubmed">38213637</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu H., Ambikan A.T., Gabriel E.E., Svensson Akusj&#xe4;rvi S., Palaniappan A.N., Sundaraj V., Mupanni N.R., Sperk M., Cheedarla N., Sridhar R., et al. Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living with HIV on Long Term Suppressive Antiretroviral Therapy. Front. Immunol. 2019;10:1965. doi: 10.3389/fimmu.2019.01965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01965</ArticleId><ArticleId IdType="pmc">PMC6718454</ArticleId><ArticleId IdType="pubmed">31507593</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett J.M., Glaser R., Malarkey W.B., Beversdorf D.Q., Peng J., Kiecolt-Glaser J.K. Inflammation and reactivation of latent herpesviruses in older adults. Brain Behav. Immun. 2012;26:739&#x2013;746. doi: 10.1016/j.bbi.2011.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.11.007</ArticleId><ArticleId IdType="pmc">PMC3370109</ArticleId><ArticleId IdType="pubmed">22155500</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts E.T., Haan M.N., Dowd J.B., Aiello A.E. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am. J. Epidemiol. 2010;172:363&#x2013;371. doi: 10.1093/aje/kwq177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq177</ArticleId><ArticleId IdType="pmc">PMC2950794</ArticleId><ArticleId IdType="pubmed">20660122</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldman W.J., Williams M.V., Jr., Lemeshow S., Binkley P., Guttridge D., Kiecolt-Glaser J.K., Knight D.A., Ladner K.J., Glaser R. Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: Evidence for depression-induced atherosclerotic risk. Brain Behav. Immun. 2008;22:215&#x2013;223. doi: 10.1016/j.bbi.2007.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2007.07.007</ArticleId><ArticleId IdType="pmc">PMC2245868</ArticleId><ArticleId IdType="pubmed">17845840</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M.E., Fuente Mde L. The role of oxidative and inflammatory stress and persistent viral infections in immunosenescence. Mech. Ageing Dev. 2016;158:27&#x2013;37. doi: 10.1016/j.mad.2016.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2016.01.001</ArticleId><ArticleId IdType="pubmed">26773975</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett D.B., Firth C.M., Phillips A.C., Moss P., Baylis D., Syddall H., Sayer A.A., Cooper C., Lord J.M. The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging Cell. 2012;11:912&#x2013;915. doi: 10.1111/j.1474-9726.2012.00849.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2012.00849.x</ArticleId><ArticleId IdType="pubmed">22708923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasimir F., Toomey D., Liu Z., Kaiping A.C., Ariza M.E., Prusty B.K. Tissue specific signature of HHV-6 infection in ME/CFS. Front. Mol. Biosci. 2022;9:1044964. doi: 10.3389/fmolb.2022.1044964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.1044964</ArticleId><ArticleId IdType="pmc">PMC9795011</ArticleId><ArticleId IdType="pubmed">36589231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lareau C.A., Yin Y., Maurer K., Sandor K.D., Daniel B., Yagnik G., Pe&#xf1;a J., Crawford J.C., Spanjaart A.M., Gutierrez J.C., et al. Latent human herpesvirus 6 is reactivated in CAR T cells. Nature. 2023;623:608&#x2013;615. doi: 10.1038/s41586-023-06704-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06704-2</ArticleId><ArticleId IdType="pmc">PMC10999258</ArticleId><ArticleId IdType="pubmed">37938768</ArticleId></ArticleIdList></Reference><Reference><Citation>Santpere G., Telford M., Andr&#xe9;s-Benito P., Navarro A., Ferrer I. The Presence of Human Herpesvirus 6 in the Brain in Health and Disease. Biomolecules. 2020;10:1520. doi: 10.3390/biom10111520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10111520</ArticleId><ArticleId IdType="pmc">PMC7694807</ArticleId><ArticleId IdType="pubmed">33172107</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumala S., Ekalaksananan T., Pientong C., Buddhisa S., Passorn S., Duangjit S., Janyakhantikul S., Suktus A., Bumrungthai S. The Association of HHV-6 and the TNF-&#x3b1; (-308G/A) Promotor with Major Depressive Disorder Patients and Healthy Controls in Thailand. Viruses. 2023;15:1898. doi: 10.3390/v15091898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15091898</ArticleId><ArticleId IdType="pmc">PMC10535374</ArticleId><ArticleId IdType="pubmed">37766304</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozhgani S.H., Rajabi F., Qurbani M., Erfani Y., Yaslianifard S., Moosavi A., Pourrostami K., Baradaran Bagheri A., Soleimani A., Behzadian F., et al. Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis. Intervirology. 2022;65:49&#x2013;57. doi: 10.1159/000517930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000517930</ArticleId><ArticleId IdType="pmc">PMC8820437</ArticleId><ArticleId IdType="pubmed">34348314</ArticleId></ArticleIdList></Reference><Reference><Citation>Boquet A., Boulay G., Hautin E., Mottard N. Septic shock complicated by disseminated herpes simplex virus-1 infection: A case report. J. Med. Case. Rep. 2021;15:394. doi: 10.1186/s13256-021-02985-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-021-02985-1</ArticleId><ArticleId IdType="pmc">PMC8349305</ArticleId><ArticleId IdType="pubmed">34364400</ArticleId></ArticleIdList></Reference><Reference><Citation>Mularoni A., Cona A., Ribeiro Dias L., Bulati M., Bus&#xe0; R., Castelbuono S., Lo Porto D., Pietrosi G., Liotta R., Conaldi P.G., et al. Cytokine storm and severe hepatitis in pregnancy due to herpes simplex virus 2. Infection. 2024;52:259&#x2013;263. doi: 10.1007/s15010-023-02092-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02092-x</ArticleId><ArticleId IdType="pmc">PMC10811078</ArticleId><ArticleId IdType="pubmed">37759073</ArticleId></ArticleIdList></Reference><Reference><Citation>Panza F., Lozupone M., Solfrizzi V., Watling M., Imbimbo B.P. Time to test antibacterial therapy in Alzheimer&#x2019;s disease. Brain. 2019;142:2905&#x2013;2929. doi: 10.1093/brain/awz244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz244</ArticleId><ArticleId IdType="pubmed">31532495</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.Y., Yang Y.X., Kuo K., Li H.Q., Shen X.N., Chen S.D., Cui M., Tan L., Dong Q., Yu J.T. Herpesvirus infections and Alzheimer&#x2019;s disease: A Mendelian randomization study. Alzheimers Res. Ther. 2021;13:158. doi: 10.1186/s13195-021-00905-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00905-5</ArticleId><ArticleId IdType="pmc">PMC8464096</ArticleId><ArticleId IdType="pubmed">34560893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Qu J., Luo L., Xu Z., Zou X. Multigenomics Reveals the Causal Effect of Herpes Simplex Virus in Alzheimer&#x2019;s Disease: A Two-Sample Mendelian Randomization Study. Front. Genet. 2022;12:773725. doi: 10.3389/fgene.2021.773725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.773725</ArticleId><ArticleId IdType="pmc">PMC8766664</ArticleId><ArticleId IdType="pubmed">35069681</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzaro C., Quartuccio L., Adinolfi L.E., Roccatello D., Pozzato G., Nevola R., Tonizzo M., Gitto S., Andreone P., Gattei V. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy. Viruses. 2021;13:2249. doi: 10.3390/v13112249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112249</ArticleId><ArticleId IdType="pmc">PMC8619859</ArticleId><ArticleId IdType="pubmed">34835054</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal E., Cacoub P. Extrahepatic manifestations in chronic hepatitis C virus carriers. Lupus. 2015;24:469&#x2013;482. doi: 10.1177/0961203314556140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314556140</ArticleId><ArticleId IdType="pubmed">25801890</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarapultsev A., Gusev E., Komelkova M., Utepova I., Luo S., Hu D. JAK-STAT signaling in inflammation and stress-related diseases: Implications for therapeutic interventions. Mol. Biomed. 2023;4:40. doi: 10.1186/s43556-023-00151-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43556-023-00151-1</ArticleId><ArticleId IdType="pmc">PMC10632324</ArticleId><ArticleId IdType="pubmed">37938494</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackhurst B.M., Funk K.E. Viral pathogens increase the risk of neurodegenerative disease. Nat. Rev. Neurol. 2023;19:259&#x2013;260. doi: 10.1038/s41582-023-00790-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-023-00790-6</ArticleId><ArticleId IdType="pmc">PMC9980857</ArticleId><ArticleId IdType="pubmed">36864169</ArticleId></ArticleIdList></Reference><Reference><Citation>Filgueira L., Larionov A., Lannes N. The Influence of Virus Infection on Microglia and Accelerated Brain Aging. Cells. 2021;10:1836. doi: 10.3390/cells10071836.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071836</ArticleId><ArticleId IdType="pmc">PMC8303900</ArticleId><ArticleId IdType="pubmed">34360004</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H.C., Guest P.C., Dobrowolny H., Steiner J. Inflammation and viral infection as disease modifiers in schizophrenia. Front. Psychiatry. 2023;14:1231750. doi: 10.3389/fpsyt.2023.1231750.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2023.1231750</ArticleId><ArticleId IdType="pmc">PMC10577328</ArticleId><ArticleId IdType="pubmed">37850104</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Wang S., Wu W., Chang H., Shan P., Yang L., Zhang W., Wang X. Exploring New Mechanism of Depression from the Effects of Virus on Nerve Cells. Cells. 2023;12:1767. doi: 10.3390/cells12131767.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12131767</ArticleId><ArticleId IdType="pmc">PMC10340315</ArticleId><ArticleId IdType="pubmed">37443801</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudra Rakshasa-Loots A., Whalley H.C., Vera J.H., Cox S.R. Neuroinflammation in HIV-associated depression: Evidence and future perspectives. Mol. Psychiatry. 2022;27:3619&#x2013;3632. doi: 10.1038/s41380-022-01619-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01619-2</ArticleId><ArticleId IdType="pmc">PMC9708589</ArticleId><ArticleId IdType="pubmed">35618889</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P., Zhang M. Magnetic Resonance Imaging Studies of Neurodegenerative Disease: From Methods to Translational Research. Neurosci. Bull. 2023;39:99&#x2013;112. doi: 10.1007/s12264-022-00905-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-022-00905-x</ArticleId><ArticleId IdType="pmc">PMC9849544</ArticleId><ArticleId IdType="pubmed">35771383</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K., Bohnert S., Bouchard M., Vair C., Farrell J.S., Teskey G.C., Mikler J., Dunn J.F. Quantitative T2 MRI is predictive of neurodegeneration following organophosphate exposure in a rat model. Sci. Rep. 2020;10:13007. doi: 10.1038/s41598-020-69991-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69991-z</ArticleId><ArticleId IdType="pmc">PMC7400670</ArticleId><ArticleId IdType="pubmed">32747689</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomasson M., Voruz P., Cionca A., Jacot de Alc&#xe2;ntara I., Nuber-Champier A., Allali G., Benzakour L., Lalive P.H., L&#xf6;vblad K.O., Braillard O., et al. Markers of limbic system damage following SARS-CoV-2 infection. Brain Commun. 2023;5:fcad177. doi: 10.1093/braincomms/fcad177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcad177</ArticleId><ArticleId IdType="pmc">PMC10320753</ArticleId><ArticleId IdType="pubmed">37415776</ArticleId></ArticleIdList></Reference><Reference><Citation>Llana T., Mendez M., Zorzo C., Fidalgo C., Juan M.C., Mendez-Lopez M. Anosmia in COVID-19 could be associated with long-term deficits in the consolidation of procedural and verbal declarative memories. Front. Neurosci. 2022;16:1082811. doi: 10.3389/fnins.2022.1082811.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.1082811</ArticleId><ArticleId IdType="pmc">PMC9780694</ArticleId><ArticleId IdType="pubmed">36570827</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafiz R., Gandhi T.K., Mishra S., Prasad A., Mahajan V., Di X., Natelson B.H., Biswal B.B. Higher limbic and basal ganglia volumes in surviving COVID-negative patients and the relations to fatigue. Neuroimage Rep. 2022;2:100095. doi: 10.1016/j.ynirp.2022.100095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ynirp.2022.100095</ArticleId><ArticleId IdType="pmc">PMC9040524</ArticleId><ArticleId IdType="pubmed">35496469</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolini M., Palladini M., Mazza M.G., Colombo F., Vai B., Rovere-Querini P., Falini A., Poletti S., Benedetti F. Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study. Eur. Neuropsychopharmacol. 2023;68:1&#x2013;10. doi: 10.1016/j.euroneuro.2022.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9742225</ArticleId><ArticleId IdType="pubmed">36640728</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintos-Pascual I., Moreno-Torres V., Ib&#xe1;nez-Est&#xe9;llez F., Corrales-Rodriguez P., Trevino A., Corpas M., Corral O., Soriano V., de Mendoza C. Is SARS-CoV-2 the only cause of Long COVID? AIDS Rev. 2022;24:183&#x2013;196. doi: 10.24875/AIDSRev.22000025.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/AIDSRev.22000025</ArticleId><ArticleId IdType="pubmed">36427058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayat A.H., Azimi H., Hassani Moghaddam M., Ebrahimi V., Fathi M., Vakili K., Mahmoudiasl G.R., Forouzesh M., Boroujeni M.E., Nariman Z., et al. COVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampus. Apoptosis. 2022;27:852&#x2013;868. doi: 10.1007/s10495-022-01754-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-022-01754-9</ArticleId><ArticleId IdType="pmc">PMC9310365</ArticleId><ArticleId IdType="pubmed">35876935</ArticleId></ArticleIdList></Reference><Reference><Citation>Toogood P.L., Clauw D.J., Phadke S., Hoffman D. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from? Pharmacol. Res. 2021;165:105465. doi: 10.1016/j.phrs.2021.105465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105465</ArticleId><ArticleId IdType="pubmed">33529750</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Julin P., Li T.Q. Limbic Perfusion Is Reduced in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Tomography. 2021;7:675&#x2013;687. doi: 10.3390/tomography7040056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tomography7040056</ArticleId><ArticleId IdType="pmc">PMC8628916</ArticleId><ArticleId IdType="pubmed">34842817</ArticleId></ArticleIdList></Reference><Reference><Citation>Saury J.M. The role of the hippocampus in the pathogenesis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Med. Hypotheses. 2016;86:30&#x2013;38. doi: 10.1016/j.mehy.2015.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2015.11.024</ArticleId><ArticleId IdType="pubmed">26804593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Sato W., Son C.G. Brain-regional characteristics and neuroinflammation in ME/CFS patients from neuroimaging: A systematic review and meta-analysis. Autoimmun. Rev. 2023;23:103484. doi: 10.1016/j.autrev.2023.103484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2023.103484</ArticleId><ArticleId IdType="pubmed">38016575</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatziagelaki E., Adamaki M., Tsilioni I., Dimitriadis G., Theoharides T.C. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus? J. Pharmacol. Exp. Ther. 2018;367:155&#x2013;167. doi: 10.1124/jpet.118.250845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.118.250845</ArticleId><ArticleId IdType="pubmed">30076265</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Board on the Health of Select Populations. Institute of Medicine . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press; Washington, DC, USA: 2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.17226/19012</ArticleId><ArticleId IdType="pubmed">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., Vernon S.D., Reeves W.C., Lloyd A. Dubbo Infection Outcomes Study Group. Post-infectious and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. BMJ. 2006;333:575. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson M.R. The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome. PLoS Pathog. 2023;19:e1011523. doi: 10.1371/journal.ppat.1011523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011523</ArticleId><ArticleId IdType="pmc">PMC10434940</ArticleId><ArticleId IdType="pubmed">37590180</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Campen C.L.C.V., Rowe P.C., Visser F.C. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Medicina. 2021;58:28. doi: 10.3390/medicina58010028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Retornaz F., Rebaudet S., Stavris C., Jammes Y. Long-term neuromuscular consequences of SARS-CoV-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: Results of the retrospective CoLGEM study. J. Transl. Med. 2022;20:429. doi: 10.1186/s12967-022-03638-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03638-7</ArticleId><ArticleId IdType="pmc">PMC9509619</ArticleId><ArticleId IdType="pubmed">36153556</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu K., Honda H., Sunada N., Sakurada Y., Matsuda Y., Yamamoto K., Nakano Y., Hasegawa T., Yamamoto Y., Otsuka Y., et al. Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID. Medicina. 2022;58:850. doi: 10.3390/medicina58070850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070850</ArticleId><ArticleId IdType="pmc">PMC9325226</ArticleId><ArticleId IdType="pubmed">35888568</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon S.D., Hartle M., Sullivan K., Bell J., Abbaszadeh S., Unutmaz D., Bateman L. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Work. 2023;74:1179&#x2013;1186. doi: 10.3233/WOR-220581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-220581</ArticleId><ArticleId IdType="pubmed">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Son C.G. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2020;18:289. doi: 10.1186/s12967-020-02455-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType="pmc">PMC7391812</ArticleId><ArticleId IdType="pubmed">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Aenlle K.K., Cohen J., Mathew A., Isler D., Pangeni R.P., Nathanson L., Theoharides T.C., Klimas N.G. COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions. Neuroscientist. 2023;11:10738584231194927. doi: 10.1177/10738584231194927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10738584231194927</ArticleId><ArticleId IdType="pubmed">37694571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Y., Zhang T., Cai J., Huang C., Zhan S., Liu J. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Immunol. 2022;13:952987. doi: 10.3389/fimmu.2022.952987.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.952987</ArticleId><ArticleId IdType="pmc">PMC9524193</ArticleId><ArticleId IdType="pubmed">36189286</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss A.B., Greene C., Dayaramani C., Rauchman S.H., Stecker M.M., De Leon J., Pinkhasov A. Long COVID, the Brain, Nerves, and Cognitive Function. Neurol. Int. 2023;15:821&#x2013;841. doi: 10.3390/neurolint15030052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15030052</ArticleId><ArticleId IdType="pmc">PMC10366776</ArticleId><ArticleId IdType="pubmed">37489358</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontes-Dantas F.L., Fernandes G.G., Gutman E.G., De Lima E.V., Antonio L.S., Hammerle M.B., Mota-Araujo H.P., Colodeti L.C., Ara&#xfa;jo S.M.B., Froz G.M., et al. SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep. 2023;42:112189. doi: 10.1016/j.celrep.2023.112189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112189</ArticleId><ArticleId IdType="pmc">PMC9935273</ArticleId><ArticleId IdType="pubmed">36857178</ArticleId></ArticleIdList></Reference><Reference><Citation>Golzari-Sorkheh M., Weaver D.F., Reed M.A. COVID-19 as a Risk Factor for Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 2023;91:1&#x2013;23. doi: 10.3233/JAD-220800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220800</ArticleId><ArticleId IdType="pubmed">36314211</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Chen Y., Wang Y., Ke Q., Cui L. The COVID-19 pandemic and Alzheimer&#x2019;s disease: Mutual risks and mechanisms. Transl. Neurodegener. 2022;11:40. doi: 10.1186/s40035-022-00316-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00316-y</ArticleId><ArticleId IdType="pmc">PMC9464468</ArticleId><ArticleId IdType="pubmed">36089575</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai S.N., Tiwari N., Singh P., Singh A.K., Mishra D., Imran M., Singh S., Hooshmandi E., Vamanu E., Singh S.K., et al. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson&#x2019;s and Alzheimer&#x2019;s Disease. Oxid. Med. Cell. Longev. 2022;2022:3012778. doi: 10.1155/2022/3012778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3012778</ArticleId><ArticleId IdType="pmc">PMC9453010</ArticleId><ArticleId IdType="pubmed">36092161</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadoro G., Latina V., Stigliano E., Micera A. COVID-19 and Alzheimer&#x2019;s Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future. Cells. 2023;12:2601. doi: 10.3390/cells12222601.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12222601</ArticleId><ArticleId IdType="pmc">PMC10670749</ArticleId><ArticleId IdType="pubmed">37998336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara F., Zovi A., Mas I.M., Langella R., Trama U., Boccellino M., Vitiello A. Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected. Naunyn-Schmiedeberg&#x2019;s Arch. Pharmacol. 2023;396:1583&#x2013;1589. doi: 10.1007/s00210-023-02417-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-023-02417-5</ArticleId><ArticleId IdType="pmc">PMC9918819</ArticleId><ArticleId IdType="pubmed">36773054</ArticleId></ArticleIdList></Reference><Reference><Citation>Marwaha B. Role of Tau protein in long COVID and potential therapeutic targets. Front. Cell. Infect. Microbiol. 2023;13:1280600. doi: 10.3389/fcimb.2023.1280600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1280600</ArticleId><ArticleId IdType="pmc">PMC10634420</ArticleId><ArticleId IdType="pubmed">37953801</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Olff M. Sex and gender differences in post-traumatic stress disorder: An update. Eur. J. Psychotraumatol. 2017;8:1351204. doi: 10.1080/20008198.2017.1351204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20008198.2017.1351204</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavropoulou M.P., Tsokos G.C., Chrousos G.P., Sfikakis P.P. Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID. Clin. Immunol. 2022;245:109133. doi: 10.1016/j.clim.2022.109133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.109133</ArticleId><ArticleId IdType="pmc">PMC9519365</ArticleId><ArticleId IdType="pubmed">36182048</ArticleId></ArticleIdList></Reference><Reference><Citation>Alijotas-Reig J., Anunciacion-Llunell A., Esteve-Valverde E., Morales-P&#xe9;rez S., Rivero-Santana S., Trap&#xe9; J., Gonz&#xe1;lez-Garc&#xed;a L., Ruiz D., Marques-Soares J., Miro-Mur F. Pituitary-Adrenal Axis and Peripheral Immune Cell Profile in Long COVID. Biomedicines. 2024;12:581. doi: 10.3390/biomedicines12030581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12030581</ArticleId><ArticleId IdType="pmc">PMC10968573</ArticleId><ArticleId IdType="pubmed">38540194</ArticleId></ArticleIdList></Reference><Reference><Citation>Capatina C., Poiana C., Fleseriu M. Pituitary and SARS-CoV-2: An unremitting conundrum. Best Pract. Res. Clin. Endocrinol. Metab. 2023;37:101752. doi: 10.1016/j.beem.2023.101752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2023.101752</ArticleId><ArticleId IdType="pmc">PMC9969757</ArticleId><ArticleId IdType="pubmed">36878774</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow M.K., Kwek D.S., Ng A.W., Ong K.C., Kaw G.J., Lee L.S. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Clin. Endocrinol. 2005;63:197&#x2013;202. doi: 10.1111/j.1365-2265.2005.02325.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzali A., Hatef B., Sahraei H., Meftahi G.H., Khaleghi A., Jahromi G.P. Changes in psychological and cognitive variables as well as cortisol levels in recovered COVID-19 patients: A longitudinal study. Curr. Psychol. 2023;43:12159&#x2013;12168. doi: 10.1007/s12144-022-04211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12144-022-04211-7</ArticleId><ArticleId IdType="pmc">PMC9875175</ArticleId><ArticleId IdType="pubmed">36713617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Choi Y., Joung J.Y., Son C.G. Clinical and Laboratory Characteristics of Fatigue-dominant Long COVID subjects: A Cross-Sectional Study. Am. J. Med. 2024. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2024.01.025</ArticleId><ArticleId IdType="pubmed">38331137</ArticleId></ArticleIdList></Reference><Reference><Citation>Schein J., Houle C., Urganus A., Cloutier M., Patterson-Lomba O., Wang Y., King S., Levinson W., Gu&#xe9;rin A., Lefebvre P., et al. Prevalence of post-traumatic stress disorder in the United States: A systematic literature review. Curr. Med. Res. Opin. 2021;37:2151&#x2013;2161. doi: 10.1080/03007995.2021.1978417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2021.1978417</ArticleId><ArticleId IdType="pubmed">34498953</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks M., Marks J.L. Viral arthritis. Clin. Med. 2016;16:129&#x2013;134. doi: 10.7861/clinmedicine.16-2-129.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.16-2-129</ArticleId><ArticleId IdType="pmc">PMC4868140</ArticleId><ArticleId IdType="pubmed">27037381</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari V., Bergman M.J. StatPearls [Internet] StatPearls Publishing; St. Petersburg, FL, USA: 2023. Viral Arthritis.</Citation><ArticleIdList><ArticleId IdType="pubmed">30285402</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhrbier A., Mahalingam S. The immunobiology of viral arthritides. Pharmacol. Ther. 2009;124:301&#x2013;308. doi: 10.1016/j.pharmthera.2009.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2009.09.005</ArticleId><ArticleId IdType="pubmed">19788897</ArticleId></ArticleIdList></Reference><Reference><Citation>McDougall J.J. Arthritis and pain. Neurogenic origin of joint pain. Arthritis Res. Ther. 2006;8:20. doi: 10.1186/ar2069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2069</ArticleId><ArticleId IdType="pmc">PMC1794504</ArticleId><ArticleId IdType="pubmed">17118212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoong C.W.S., Amin M.N.M.E., Tan T.C., Lee J.E. Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms. Int. J. Infect. Dis. 2021;104:363&#x2013;369. doi: 10.1016/j.ijid.2021.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.01.031</ArticleId><ArticleId IdType="pmc">PMC7813485</ArticleId><ArticleId IdType="pubmed">33476761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaffi J., Vanni E., Mancarella L., Brusi V., Lisi L., Pignatti F., Naldi S., Assirelli E., Neri S., Reta M., et al. Post-Acute COVID-19 Joint Pain and New Onset of Rheumatic Musculoskeletal Diseases: A Systematic Review. Diagnostics. 2023;13:1850. doi: 10.3390/diagnostics13111850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13111850</ArticleId><ArticleId IdType="pmc">PMC10252492</ArticleId><ArticleId IdType="pubmed">37296705</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., &#xc1; Steig B., Gaini S., Str&#xf8;m M., Weihe P. Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients. Clin. Infect. Dis. 2021;73:e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Roseti L., Grigolo B. COVID-19 and rheumatic diseases: A mini-review. Front. Med. 2022;9:997876. doi: 10.3389/fmed.2022.997876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.997876</ArticleId><ArticleId IdType="pmc">PMC9548696</ArticleId><ArticleId IdType="pubmed">36226148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota H.R., Nune A. Long COVID from rheumatology perspective&#x2014;A narrative review. Clin. Rheumatol. 2022;41:337&#x2013;348. doi: 10.1007/s10067-021-06001-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-06001-1</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan Y., Grodzinsky A.J. Cartilage diseases. Matrix Biol. 2018;71&#x2013;72:51&#x2013;69. doi: 10.1016/j.matbio.2018.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2018.05.005</ArticleId><ArticleId IdType="pmc">PMC6146013</ArticleId><ArticleId IdType="pubmed">29803938</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlier E., Deroyer C., Ciregia F., Malaise O., Neuville S., Plener Z., Malaise M., de Seny D. Chondrocyte dedifferentiation and osteoarthritis (OA) Biochem. Pharmacol. 2019;165:49&#x2013;65. doi: 10.1016/j.bcp.2019.02.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2019.02.036</ArticleId><ArticleId IdType="pubmed">30853397</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauwers M., Au M., Yuan S., Wen C. COVID-19 in Joint Aging and Osteoarthritis: Current Status and Perspectives. Int. J. Mol. Sci. 2022;23:720. doi: 10.3390/ijms23020720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020720</ArticleId><ArticleId IdType="pmc">PMC8775477</ArticleId><ArticleId IdType="pubmed">35054906</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarantino U., Visconti V.V., Bonanni R., Gatti A., Marcozzi M., Calabr&#xf2; D., Cariati I. Osteosarcopenia and Long COVID: A dangerous combination. Ther. Adv. Musculoskelet. Dis. 2022;14:1759720X221130485. doi: 10.1177/1759720X221130485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X221130485</ArticleId><ArticleId IdType="pmc">PMC9614591</ArticleId><ArticleId IdType="pubmed">36317068</ArticleId></ArticleIdList></Reference><Reference><Citation>Freund O., Eviatar T., Bornstein G. Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: A case series and literature review. Rheumatol. Int. 2022;42:905&#x2013;912. doi: 10.1007/s00296-022-05106-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05106-3</ArticleId><ArticleId IdType="pmc">PMC8915139</ArticleId><ArticleId IdType="pubmed">35275269</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T., Stenzel W. COVID-19 associated myopathy. Curr. Opin. Neurol. 2022;35:622&#x2013;628. doi: 10.1097/WCO.0000000000001101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001101</ArticleId><ArticleId IdType="pubmed">35950722</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejb&#xf8;l E.K., Harbo T., Agergaard J., Madsen L.B., Pedersen T.H., &#xd8;stergaard L.J., Andersen H., Schr&#xf8;der H.D., Tankisi H. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology. Eur. J. Neurol. 2022;29:2832&#x2013;2841. doi: 10.1111/ene.15435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15435</ArticleId><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-V&#xe9;lez R., Legarra-Gorgo&#xf1;on G., Oscoz-Ochandorena S., Garc&#xed;a-Alonso Y., Garc&#xed;a-Alonso N., Oteiza J., Ernaga Lorea A., Correa-Rodriguez M., Izquierdo M. Reduced muscle strength in patients with Long COVID-19 syndrome is mediated by limb muscle mass. J. Appl. Physiol. 2023;134:50&#x2013;58. doi: 10.1152/japplphysiol.00599.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00599.2022</ArticleId><ArticleId IdType="pmc">PMC9762963</ArticleId><ArticleId IdType="pubmed">36448687</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankisi H., Ochala J. Myopathy in acute and long-term COVID-19. Clin. Neurophysiol. 2022;134:141&#x2013;142. doi: 10.1016/j.clinph.2021.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.11.006</ArticleId><ArticleId IdType="pmc">PMC8654456</ArticleId><ArticleId IdType="pubmed">34930658</ArticleId></ArticleIdList></Reference><Reference><Citation>Agergaard J., Yamin Ali Khan B., Engell-S&#xf8;rensen T., Schi&#xf8;ttz-Christensen B., &#xd8;stergaard L., Hejb&#xf8;l E.K., Schr&#xf8;der H.D., Andersen H., Blicher J.U., Holm Pedersen T., et al. MULTICOV Consortium. Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology. Clin. Neurophysiol. 2023;148:65&#x2013;75. doi: 10.1016/j.clinph.2023.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2023.01.010</ArticleId><ArticleId IdType="pubmed">36804609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocci T., Bertini A., Campiglio L., Botta S., Libelli G., Guidetti M., Priori A. Not myopathic, but autonomic changes in patients with Long COVID syndrome: A case series. Neurol. Sci. 2023;44:1147&#x2013;1153. doi: 10.1007/s10072-023-06637-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-023-06637-8</ArticleId><ArticleId IdType="pmc">PMC9896447</ArticleId><ArticleId IdType="pubmed">36735149</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapra L., Saini C., Garg B., Gupta R., Verma B., Mishra P.K., Srivastava R.K. Long-term implications of COVID-19 on bone health: Pathophysiology and therapeutics. Inflamm. Res. 2022;71:1025&#x2013;1040. doi: 10.1007/s00011-022-01616-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-022-01616-9</ArticleId><ArticleId IdType="pmc">PMC9330992</ArticleId><ArticleId IdType="pubmed">35900380</ArticleId></ArticleIdList></Reference><Reference><Citation>Haudenschild A.K., Christiansen B.A., Orr S., Ball E.E., Weiss C.M., Liu H., Fyhrie D.P., Yik J.H.N., Coffey L.L., Haudenschild D.R. Acute bone loss following SARS-CoV-2 infection in mice. J. Orthop. Res. 2023;41:1945&#x2013;1952. doi: 10.1002/jor.25537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jor.25537</ArticleId><ArticleId IdType="pmc">PMC10440245</ArticleId><ArticleId IdType="pubmed">36815216</ArticleId></ArticleIdList></Reference><Reference><Citation>Buccino F., Zagra L., Longo E., D&#x2019;Amico L., Banfi G., Berto F., Tromba G., Vergani L.M. Osteoporosis and COVID-19: Detected similarities in bone lacunar-level alterations via combined AI and advanced synchrotron testing. Mater. Des. 2023;231:112087. doi: 10.1016/j.matdes.2023.112087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matdes.2023.112087</ArticleId><ArticleId IdType="pmc">PMC10257887</ArticleId><ArticleId IdType="pubmed">37323219</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Shi W., Zhang X., Pang R., Liang X., Xu Q., Xu C., Wan X., Cui W., Li D., et al. Causal relationships between COVID-19 and osteoporosis: A two-sample Mendelian randomization study in European population. Front. Public Health. 2023;11:1122095. doi: 10.3389/fpubh.2023.1122095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1122095</ArticleId><ArticleId IdType="pmc">PMC10244501</ArticleId><ArticleId IdType="pubmed">37293613</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin de Francisco A., Fern&#xe1;ndez Fresnedo G. Long COVID-19 renal disease: A present medical need for nephrology. Nephrologia. 2023;43:1&#x2013;5. doi: 10.1016/j.nefroe.2023.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nefroe.2023.03.011</ArticleId><ArticleId IdType="pmc">PMC10060193</ArticleId><ArticleId IdType="pubmed">37031074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudose S., Santoriello D., Bomback A.S., Sekulic M., Batal I., Stokes M.B., Ghavami I.A., Kim J.S., Marasa M., Xu K., et al. Longitudinal Outcomes of COVID-19-Associated Collapsing Glomerulopathy and Other Podocytopathies. J. Am. Soc. Nephrol. 2021;32:2958&#x2013;2969. doi: 10.1681/ASN.2021070931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021070931</ArticleId><ArticleId IdType="pmc">PMC8806099</ArticleId><ArticleId IdType="pubmed">34670811</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen J., Reimer K.C., Nagai J.S., Varghese F.S., Overheul G.J., de Beer M., Roverts R., Daviran D., Fermin L.A.S., Willemsen B., et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2022;29:217&#x2013;231.e8. doi: 10.1016/j.stem.2021.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.12.010</ArticleId><ArticleId IdType="pmc">PMC8709832</ArticleId><ArticleId IdType="pubmed">35032430</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrett R.E., Palacio C.H., Bar-Or D. Long COVID: Is there a kidney link? Front. Med. 2023;10:1138644. doi: 10.3389/fmed.2023.1138644.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1138644</ArticleId><ArticleId IdType="pmc">PMC10106649</ArticleId><ArticleId IdType="pubmed">37077670</ArticleId></ArticleIdList></Reference><Reference><Citation>Grootemaat A.E., Wiersma N., van der Niet S., Schimmel I.M., Florquin S., Reits E.A., Miller S.E., van der Wel N.N. Nucleocapsid protein accumulates in renal tubular epithelium of a post-COVID-19 patient. Microbiol. Spectr. 2023;11:e0302923. doi: 10.1128/spectrum.03029-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.03029-23</ArticleId><ArticleId IdType="pmc">PMC10715010</ArticleId><ArticleId IdType="pubmed">37975661</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima I.C., de Menezes D.C., Uesugi J.H.E., Bichara C.N.C., da Costa Vasconcelos P.F., Quaresma J.A.S., Falc&#xe3;o L.F.M. Liver Function in Patients with Long-Term Coronavirus Disease 2019 of up to 20 Months: A Cross-Sectional Study. Int. J. Environ. Res. Public Health. 2023;20:5281. doi: 10.3390/ijerph20075281.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20075281</ArticleId><ArticleId IdType="pmc">PMC10094195</ArticleId><ArticleId IdType="pubmed">37047897</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassan M., Mescoli C., Sbaraglia M., Guzzardo V., Russo F.P., Fabris R., Trevenzoli M., Pelizzaro F., Cattelan A.M., Basso C., et al. Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens. Pathol. Res. Pract. 2021;221:153451. doi: 10.1016/j.prp.2021.153451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2021.153451</ArticleId><ArticleId IdType="pmc">PMC8054534</ArticleId><ArticleId IdType="pubmed">33932720</ArticleId></ArticleIdList></Reference><Reference><Citation>Backer S., Khanna D. The Lasting Effects of COVID-19 on the Progression of Metabolic Dysfunction-Associated Steatic Liver Disease (MASLD) Cureus. 2023;15:e45231. doi: 10.7759/cureus.45231.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.45231</ArticleId><ArticleId IdType="pmc">PMC10576539</ArticleId><ArticleId IdType="pubmed">37842470</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth N.C., Kim A., Vitkovski T., Xia J., Ramirez G., Bernstein D., Crawford J.M. Post-COVID-19 Cholangiopathy: A Novel Entity. Am. J. Gastroenterol. 2021;116:1077&#x2013;1082. doi: 10.14309/ajg.0000000000001154.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001154</ArticleId><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Spengler U., Fischer H.P., Caselmann W.H. Liver Disease Associated with Viral Infections. Zakim Boyer&#x2019;s Hepatol. 2012:629&#x2013;643. doi: 10.1016/B978-1-4377-0881-3.00034-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-1-4377-0881-3.00034-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B., Siqueira S., de Assis Soares W.R., de Souza Rangel F., Santos N.O., Dos Santos Freitas A., Ribeiro da Silveira P., Tiwari S., Alzahrani K.J., Goes-Neto A., et al. Long COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021;13:700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanne J.H. COVID-19: Even mild infections can cause long term heart problems, large study finds. BMJ. 2022;376:o378. doi: 10.1136/bmj.o378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o378</ArticleId><ArticleId IdType="pubmed">35165093</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfa;&#xf1;ez-Gil I.J., Feltes G., Viana-Llamas M.C., Raposeiras-Roubin S., Romero R., Alfonso-Rodriguez E., Uribarri A., Santoro F., Becerra-Mu&#xf1;oz V., HOPE-2 Investigators et al. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2) J. Clin. Med. 2023;12:706. doi: 10.3390/jcm12020706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020706</ArticleId><ArticleId IdType="pmc">PMC9863454</ArticleId><ArticleId IdType="pubmed">36675633</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi J. The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks. JAMA. 2022;327:1113&#x2013;1114. doi: 10.1001/jama.2022.2411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.2411</ArticleId><ArticleId IdType="pubmed">35234824</ArticleId></ArticleIdList></Reference><Reference><Citation>Davoudi F., Miyashita S., Yoo T.K., Lee P.T., Foster G.P. An Insight into Pathophysiology, Epidemiology, and Management of Cardiovascular Complications of SARS-CoV-2 Infection, Post-acute COVID Syndrome, and COVID Vaccine. Crit. Pathw Cardiol. 2022;21:123&#x2013;129. doi: 10.1097/HPC.0000000000000290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HPC.0000000000000290</ArticleId><ArticleId IdType="pubmed">35994720</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma C., Bayry J. High risk of autoimmune diseases after COVID-19. Nat. Rev. Rheumatol. 2023;19:399&#x2013;400. doi: 10.1038/s41584-023-00964-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-023-00964-y</ArticleId><ArticleId IdType="pmc">PMC10096101</ArticleId><ArticleId IdType="pubmed">37046064</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R., Chen Y.-T., Wang S.I., Hung Y.M., Chen H.Y., Wei C.J. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. eClinicalMedicine. 2023;56:101783. doi: 10.1016/j.eclinm.2022.101783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101783</ArticleId><ArticleId IdType="pmc">PMC9830133</ArticleId><ArticleId IdType="pubmed">36643619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesch F., Ehm F., Vivirito A., Wende D., Batram M., Loser F., Menzer S., Jacob J., Roessler M., Seifert M., et al. Incident autoimmune diseases in association with SARS-CoV-2 infection: A matched cohort study. Clin. Rheumatol. 2023;42:2905&#x2013;2914. doi: 10.1007/s10067-023-06670-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-023-06670-0</ArticleId><ArticleId IdType="pmc">PMC10497688</ArticleId><ArticleId IdType="pubmed">37335408</ArticleId></ArticleIdList></Reference><Reference><Citation>Daines L., Zheng B., Pfeffer P., Hurst J.R., Sheikh A. A clinical review of Long COVID with a focus on the respiratory system. Curr. Opin. Pulm. Med. 2022;28:174&#x2013;179. doi: 10.1097/MCP.0000000000000863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCP.0000000000000863</ArticleId><ArticleId IdType="pmc">PMC7612723</ArticleId><ArticleId IdType="pubmed">35131989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N., Zhao Y.M., Yan W., Li C., Lu Q.D., Liu L., Ni S.Y., Mei H., Yuan K., Shi L., et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: Call for research priority and action. Mol. Psychiatry. 2023;28:423&#x2013;433. doi: 10.1038/s41380-022-01614-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevenini E., Caruso C., Candore G., Capri M., Nuzzo D., Duro G., Rizzo C., Colonna-Romano G., Lio D., Di Carlo D., et al. Age-related inflammation: The contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr. Pharm. Des. 2010;16:609&#x2013;618. doi: 10.2174/138161210790883840.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161210790883840</ArticleId><ArticleId IdType="pubmed">20388071</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers-Auty J., Mather A.E., Peters R., Lawrence C.B., Brough D. Anti-inflammatories in Alzheimer&#x2019;s disease-potential therapy or spurious correlate? Brain Commun. 2020;2:fcaa109. doi: 10.1093/braincomms/fcaa109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa109</ArticleId><ArticleId IdType="pmc">PMC7585697</ArticleId><ArticleId IdType="pubmed">33134914</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf S., Mander A., Ugoni A., Vajda F., Christophidis N. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer&#x2019;s disease. Neurology. 1999;53:197&#x2013;201. doi: 10.1212/wnl.53.1.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.53.1.197</ArticleId><ArticleId IdType="pubmed">10408559</ArticleId></ArticleIdList></Reference><Reference><Citation>ADAPT Research Group. Lyketsos C.G., Breitner J.C., Green R.C., Martin B.K., Meinert C., Piantadosi S., Sabbagh M. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology. 2007;68:1800&#x2013;1808. doi: 10.1212/01.wnl.0000260269.93245.d2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260269.93245.d2</ArticleId><ArticleId IdType="pubmed">17460158</ArticleId></ArticleIdList></Reference><Reference><Citation>Green R.C., Schneider L.S., Amato D.A., Beelen A.P., Wilcock G., Swabb E.A., Zavitz K.H., Tarenflurbil Phase 3 Study Group Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: A randomized controlled trial. JAMA. 2009;302:2557&#x2013;2564. doi: 10.1001/jama.2009.1866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1866</ArticleId><ArticleId IdType="pmc">PMC2902875</ArticleId><ArticleId IdType="pubmed">20009055</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasqualetti P., Bonomini C., Dal Forno G., Paulon L., Sinforiani E., Marra C., Zanetti O., Rossini P.M. A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer&#x2019;s disease. Aging Clin. Exp. Res. 2009;21:102&#x2013;110. doi: 10.1007/BF03325217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03325217</ArticleId><ArticleId IdType="pubmed">19448381</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Disease Anti-inflammatory Prevention Trial Research Group Results of a follow-up study to the randomized Alzheimer&#x2019;s Disease Anti-inflammatory Prevention Trial (ADAPT) Alzheimers Dement. 2013;9:714&#x2013;723. doi: 10.1016/j.jalz.2012.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2012.11.012</ArticleId><ArticleId IdType="pmc">PMC3823756</ArticleId><ArticleId IdType="pubmed">23562431</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrank W.H., Patrick A.R., Brookhart M.A. Healthy user and related biases in observational studies of preventive interventions: A primer for physicians. J. Gen. Intern. Med. 2011;26:546&#x2013;550. doi: 10.1007/s11606-010-1609-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-010-1609-1</ArticleId><ArticleId IdType="pmc">PMC3077477</ArticleId><ArticleId IdType="pubmed">21203857</ArticleId></ArticleIdList></Reference><Reference><Citation>Martyn C. Anti-inflammatory drugs and Alzheimer&#x2019;s disease. BMJ. 2003;327:353&#x2013;354. doi: 10.1136/bmj.327.7411.353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7411.353</ArticleId><ArticleId IdType="pmc">PMC1126777</ArticleId><ArticleId IdType="pubmed">12919966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Peluso M.J., Rodgers K., Aberg J.A., Patterson T.F., Tamburro R., Baizer L., Goldman J.D., Rouphael N., Deitchman A., et al. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative. Front. Immunol. 2023;14:1129459. doi: 10.3389/fimmu.2023.1129459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1129459</ArticleId><ArticleId IdType="pmc">PMC10034329</ArticleId><ArticleId IdType="pubmed">36969241</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio-Ruiz M.E., Guarner-Lans V., P&#xe9;rez-Torres I., Soto M.E. Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures. Int. J. Mol. Sci. 2019;20:647. doi: 10.3390/ijms20030647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20030647</ArticleId><ArticleId IdType="pmc">PMC6387003</ArticleId><ArticleId IdType="pubmed">30717377</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellucci P.N., Gonz&#xe1;lez Bagnes M.F., Di Girolamo G., Gonz&#xe1;lez C.D. Potential Effects of Nonsteroidal Anti-Inflammatory Drugs in the Prevention and Treatment of Type 2 Diabetes Mellitus. J. Pharm. Pract. 2017;30:549&#x2013;556. doi: 10.1177/0897190016649551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0897190016649551</ArticleId><ArticleId IdType="pubmed">27194069</ArticleId></ArticleIdList></Reference><Reference><Citation>Kury&#x142;owicz A., Ko&#x17a;niewski K. Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes. Molecules. 2020;25:2224. doi: 10.3390/molecules25092224.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25092224</ArticleId><ArticleId IdType="pmc">PMC7249034</ArticleId><ArticleId IdType="pubmed">32397353</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N., Cooper C., Reginster J.Y., Hochberg M., Branco J., Bruy&#xe8;re O., Chapurlat R., Al-Daghri N., Dennison E., Herrero-Beaumont G., et al. Type 2 diabetes mellitus and osteoarthritis. Semin. Arthritis Rheum. 2019;49:9&#x2013;19. doi: 10.1016/j.semarthrit.2019.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2019.01.005</ArticleId><ArticleId IdType="pmc">PMC6642878</ArticleId><ArticleId IdType="pubmed">30712918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro H., Rodrigues I., Napole&#xe3;o L., Lira L., Marques D., Ver&#xed;ssimo M., Andrade J.P., Dourado M. Non-steroidal anti-inflammatory drugs (NSAIDs), pain and aging: Adjusting prescription to patient features. Biomed. Pharmacother. 2022;150:112958. doi: 10.1016/j.biopha.2022.112958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.112958</ArticleId><ArticleId IdType="pubmed">35453005</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarberg B.H. NSAIDs in the older patient: Balancing benefits and harms. Pain Med. 2013;14((Suppl. S1)):S43&#x2013;S44. doi: 10.1111/pme.12253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pme.12253</ArticleId><ArticleId IdType="pubmed">24373111</ArticleId></ArticleIdList></Reference><Reference><Citation>LaForge J.M., Urso K., Day J.M., Bourgeois C.W., Ross M.M., Ahmadzadeh S., Shekoohi S., Cornett E.M., Kaye A.M., Kaye A.D. Non-steroidal Anti-inflammatory Drugs: Clinical Implications, Renal Impairment Risks, and AKI. Adv. Ther. 2023;40:2082&#x2013;2096. doi: 10.1007/s12325-023-02481-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-023-02481-6</ArticleId><ArticleId IdType="pubmed">36947330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushner P., McCarberg B.H., Grange L., Kolosov A., Haveric A.L., Zucal V., Petruschke R., Bissonnette S. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19. NPJ Prim. Care Respir. Med. 2022;32:35. doi: 10.1038/s41533-022-00300-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41533-022-00300-z</ArticleId><ArticleId IdType="pmc">PMC9489480</ArticleId><ArticleId IdType="pubmed">36127354</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese J.T., Coleman B., Chan L., Blau H., Callahan T.J., Cappelletti L., Fontana T., Bradwell K.R., Harris N.L., Casiraghi E., et al. NSAID use and clinical outcomes in COVID-19 patients: A 38-center retrospective cohort study. Virol. J. 2022;19:84. doi: 10.1186/s12985-022-01813-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01813-2</ArticleId><ArticleId IdType="pmc">PMC9107579</ArticleId><ArticleId IdType="pubmed">35570298</ArticleId></ArticleIdList></Reference><Reference><Citation>Laughey W., Lodhi I., Pennick G., Smart L., Sanni O., Sandhu S., Charlesworth B. Ibuprofen, other NSAIDs and COVID-19: A narrative review. Inflammopharmacology. 2023;31:2147&#x2013;2159. doi: 10.1007/s10787-023-01309-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01309-7</ArticleId><ArticleId IdType="pmc">PMC10518289</ArticleId><ArticleId IdType="pubmed">37603158</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler U.C. Low-grade inflammation in chronic diseases: An integrative pathophysiology anticipated by homeopathy? Med. Hypotheses. 2011;76:622&#x2013;626. doi: 10.1016/j.mehy.2010.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2010.12.019</ArticleId><ArticleId IdType="pubmed">21277692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R.X., Zhou M., Ma H.L., Qiao Y.B., Li Q.S. The Role of Chronic Inflammation in Various Diseases and Anti-inflammatory Therapies Containing Natural Products. ChemMedChem. 2021;16:1576&#x2013;1592. doi: 10.1002/cmdc.202000996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.202000996</ArticleId><ArticleId IdType="pubmed">33528076</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Halim A., Halim M., Ming L.C., Goh K.W., Alfaresi M., AlShehail B.M., Al Fares M.A., Alissa M., Sulaiman T., et al. Experimental drugs in randomized controlled trials for long-COVID: What&#x2019;s in the pipeline? A systematic and critical review. Expert Opin. Investig. Drugs. 2023;32:655&#x2013;667. doi: 10.1080/13543784.2023.2242773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2023.2242773</ArticleId><ArticleId IdType="pubmed">37534972</ArticleId></ArticleIdList></Reference><Reference><Citation>Beloglazov V., Yatskov I., Dudchenko L., Dubuske L. Effect of Rebamipide on Low-Grade Inflammation in Post COVID-19 Syndrome Patients. J. Allergy Clin. Immunol. 2024;153:AB189. doi: 10.1016/j.jaci.2023.11.611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2023.11.611</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K., Diethelm-Varela B., Rodr&#xed;guez-Guilarte L., Rivera T., Riedel C.A., Gonz&#xe1;lez P.A., Kalergis A.M. Pathophysiological, immunological, and inflammatory features of long COVID. Front. Immunol. 2024;15:1341600. doi: 10.3389/fimmu.2024.1341600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1341600</ArticleId><ArticleId IdType="pmc">PMC10932978</ArticleId><ArticleId IdType="pubmed">38482000</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao T., Huang Y., Sun H., Yang L. Research progress of post-acute sequelae after SARS-CoV-2 infection. Cell Death Dis. 2024;15:257. doi: 10.1038/s41419-024-06642-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-024-06642-5</ArticleId><ArticleId IdType="pmc">PMC11009241</ArticleId><ArticleId IdType="pubmed">38605011</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogariu A.M., Dumitrascu D.L. Digestive involvement in the Long-COVID syndrome. Med. Pharm. Rep. 2022;95:5&#x2013;10. doi: 10.15386/mpr-2340.</Citation><ArticleIdList><ArticleId IdType="doi">10.15386/mpr-2340</ArticleId><ArticleId IdType="pmc">PMC9177081</ArticleId><ArticleId IdType="pubmed">35720240</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasier K.M., Gallagher-Poehls C., Cochrane M., Roy D. Secondary Vasculitis Attributable to Post-COVID Syndrome. Cureus. 2023;15:e44119. doi: 10.7759/cureus.44119.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.44119</ArticleId><ArticleId IdType="pmc">PMC10456143</ArticleId><ArticleId IdType="pubmed">37638271</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J., Lee M., Kim M., Kim H.J., Lee S.W., Rhee S.Y., Koyanagi A., Smith L., Kim M.S., Lee H., et al. Incident allergic diseases in post-COVID-19 condition: Multinational cohort studies from South Korea, Japan and the UK. Nat. Commun. 2024;15:2830. doi: 10.1038/s41467-024-47176-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-47176-w</ArticleId><ArticleId IdType="pmc">PMC10987608</ArticleId><ArticleId IdType="pubmed">38565542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff D., Drewitz K.P., Ulrich A., Siegels D., Deckert S., Sprenger A.A., Kuper P.R., Schmitt J., Munblit D., Apfelbacher C. Allergic diseases as risk factors for Long-COVID symptoms: Systematic review of prospective cohort studies. Clin. Exp. Allergy. 2023;53:1162&#x2013;1176. doi: 10.1111/cea.14391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.14391</ArticleId><ArticleId IdType="pubmed">37936547</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorchenko Y., Zimba O. Long COVID in autoimmune rheumatic diseases. Rheumatol. Int. 2023;43:1197&#x2013;1207. doi: 10.1007/s00296-023-05319-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-023-05319-0</ArticleId><ArticleId IdType="pmc">PMC10061411</ArticleId><ArticleId IdType="pubmed">36995436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Li H.J., Wasuwanich P., Kim S.E., Kim J.Y., Jeong G.H., Park S., Yang J.W., Kim M.S., Yon D.K., et al. COVID-19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta-analysis. Rev. Med. Virol. 2023;33:e2414. doi: 10.1002/rmv.2414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2414</ArticleId><ArticleId IdType="pmc">PMC9877653</ArticleId><ArticleId IdType="pubmed">36504172</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray H.C., Muleme M., Cooper D., McNamara B.J., Hussain M.A., Bartolo C., O&#x2019;Brien D.P., Athan E. Prevalence, risk factors and outcomes of secondary infections among hospitalised patients with COVID-19 or post-COVID-19 conditions in Victoria, 2020&#x2013;2023. Int. J. Infect. Dis. 2024;145:107078. doi: 10.1016/j.ijid.2024.107078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2024.107078</ArticleId><ArticleId IdType="pubmed">38697606</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>